data_2n93_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n93 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 16' ' ' PHE . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.547 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 14' ' ' GLU . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.49 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.547 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 35' ' ' SER . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' ALA . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.409 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 ' H ' ' A' ' 63' ' ' VAL 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' H ' HD11 ' A' ' 62' ' ' ILE . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.502 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' GLY . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 96' ' ' PRO . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HD3' ' CD1' ' A' ' 114' ' ' LEU . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 105' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 15' ' ' ASN . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.586 ' HH ' ' HA ' ' A' ' 109' ' ' ASP . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.405 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 34' ' ' ASN . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 0.3 OUTLIER -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.425 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.457 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.699 ' HG ' ' CE ' ' A' ' 116' ' ' MET . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.586 ' HA ' ' HH ' ' A' ' 8' ' ' TYR . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD13 ' CE1' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.699 ' CE ' ' HG ' ' A' ' 93' ' ' SER . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.442 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 HD22 ' A' ' 34' ' ' ASN . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 ' CB ' ' A' ' 20' ' ' LEU . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.448 HD22 HD12 ' A' ' 20' ' ' LEU . 12.1 m120 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.457 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.464 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 114' ' ' LEU . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.442 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.406 ' HZ2' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.475 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.475 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.491 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 105' ' ' TYR . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.401 HH22 ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.527 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.527 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' H ' HD11 ' A' ' 10' ' ' LEU . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.439 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . 0.487 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.626 ' HG1' HG22 ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.626 HG22 ' HG1' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.467 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.466 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.475 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 27' ' ' GLN . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 51' ' ' PHE . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.423 ' CG1' HD22 ' A' ' 45' ' ' ASN . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.423 HD22 ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.414 ' HB2' HG23 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG22 ' HH ' ' A' ' 105' ' ' TYR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.639 ' HG ' ' CE ' ' A' ' 116' ' ' MET . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.511 ' HH ' HG22 ' A' ' 91' ' ' VAL . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 105' ' ' TYR . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.639 ' CE ' ' HG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.415 -0.216 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' HG1' ' A' ' 73' ' ' THR . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.458 ' HG1' ' HG3' ' A' ' 32' ' ' LYS . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.418 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 40' ' ' TYR . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.428 0.156 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.517 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.521 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 80' ' ' SER . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.582 ' HG ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.53 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.53 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -39.95 143.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 121.536 1.971 . . . . 0.0 112.546 163.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 16' ' ' PHE . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.547 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.44 ' H ' ' C ' ' A' ' 14' ' ' GLU . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.49 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.402 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.547 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.66 149.89 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.985 1.266 . . . . 0.0 111.213 163.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.452 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.502 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.422 ' C ' ' H ' ' A' ' 35' ' ' SER . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 33' ' ' ALA . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.409 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.49 HD11 ' H ' ' A' ' 63' ' ' VAL 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' H ' HD11 ' A' ' 62' ' ' ILE . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.502 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.44 ' O ' ' HE3' ' A' ' 83' ' ' LYS . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.44 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.479 HG22 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 98' ' ' GLY . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 96' ' ' PRO . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HD3' ' CD1' ' A' ' 114' ' ' LEU . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' A' ' 105' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' CG ' ' A' ' 15' ' ' ASN . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.427 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mtm . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -130.73 139.89 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.331 1.423 . . . . 0.0 108.62 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.586 ' HH ' ' HA ' ' A' ' 109' ' ' ASP . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.405 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' CD1' ' HB2' ' A' ' 34' ' ' ASN . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 0.3 OUTLIER -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.425 ' CZ ' HD23 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.425 HD23 ' CZ ' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.457 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.699 ' HG ' ' CE ' ' A' ' 116' ' ' MET . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE1' HG13 ' A' ' 91' ' ' VAL . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.586 ' HA ' ' HH ' ' A' ' 8' ' ' TYR . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD13 ' CE1' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.699 ' CE ' ' HG ' ' A' ' 93' ' ' SER . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.422 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.405 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ptm . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -161.15 128.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 121.329 1.877 . . . . 0.0 110.352 177.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.442 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.47 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.448 HD12 HD22 ' A' ' 34' ' ' ASN . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 ' CB ' ' A' ' 20' ' ' LEU . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.448 HD22 HD12 ' A' ' 20' ' ' LEU . 12.1 m120 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.457 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.453 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.464 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CD2' ' HB3' ' A' ' 114' ' ' LEU . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.442 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tmm? . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.74 153.64 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.49 1.495 . . . . 0.0 111.775 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.545 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.545 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.406 ' HZ2' HG11 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.475 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.475 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.491 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.491 ' CE2' ' HB3' ' A' ' 105' ' ' TYR . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 104' ' ' THR . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.401 HH22 ' HG2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -152.92 154.99 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.645 1.111 . . . . 0.0 109.564 175.475 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 ' H ' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.527 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.527 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' CB ' HG23 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' H ' HD11 ' A' ' 10' ' ' LEU . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.439 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . 0.487 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.626 ' HG1' HG22 ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.626 HG22 ' HG1' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.467 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.467 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.466 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 125' ' ' ARG . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.432 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.446 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.443 ' CD1' ' HA ' ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.507 2.421 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.85 145.08 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.492 1.917 . . . . 0.0 108.737 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.475 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.508 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.508 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.4 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 27' ' ' GLN . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 51' ' ' PHE . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.423 ' CG1' HD22 ' A' ' 45' ' ' ASN . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.423 HD22 ' CG1' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.414 ' HB2' HG23 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.429 ' CD2' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG22 ' HH ' ' A' ' 105' ' ' TYR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.639 ' HG ' ' CE ' ' A' ' 116' ' ' MET . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.511 ' HH ' HG22 ' A' ' 91' ' ' VAL . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.461 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 105' ' ' TYR . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.639 ' CE ' ' HG ' ' A' ' 93' ' ' SER . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.478 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.277 14.8 ttt . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -50.43 148.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.229 0.922 . . . . 0.0 110.415 163.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.479 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.479 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HG3' ' HG1' ' A' ' 73' ' ' THR . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.4 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 49' ' ' PHE . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.458 ' HG1' ' HG3' ' A' ' 32' ' ' LYS . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.487 ' H ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.19 138.57 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.767 1.627 . . . . 0.0 109.105 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.428 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.501 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.501 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.449 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.418 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.418 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.466 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.466 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.41 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.468 ' CE2' ' CD1' ' A' ' 40' ' ' TYR . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.6 ttt . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.08 151.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.707 1.594 . . . . 0.0 111.349 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.426 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.517 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.521 ' N ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.517 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.41 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' H ' HD12 ' A' ' 4' ' ' LEU . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 80' ' ' SER . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.582 ' HG ' HG13 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.53 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.479 ' HE3' HD11 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.53 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.479 HD11 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.436 HD21 ' HG ' ' A' ' 95' ' ' LEU . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 55' ' ' SER . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 8' ' ' TYR . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 41' ' ' GLU . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 82' ' ' THR . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' HB1' ' A' ' 33' ' ' ALA . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 61' ' ' LEU . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 82' ' ' THR . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD2' HD13 ' A' ' 114' ' ' LEU . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 114' ' ' LEU . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' CYS . . . . . 0.432 ' HA ' HG12 ' A' ' 122' ' ' VAL . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 117' ' ' CYS . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.624 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HD21 ' A' ' 10' ' ' LEU . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' CG ' ' HA ' ' A' ' 123' ' ' ALA . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 26' ' ' PRO . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 74' ' ' VAL . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' HD11 ' A' ' 20' ' ' LEU . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' A' ' 20' ' ' LEU . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 10' ' ' LEU . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 107' ' ' PHE . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 82' ' ' THR . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' THR 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 84' ' ' LEU . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG12 ' HB1' ' A' ' 33' ' ' ALA . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' VAL . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' A' ' 91' ' ' VAL . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HB2' HG21 ' A' ' 44' ' ' VAL . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' MET . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.648 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE1' HG23 ' A' ' 30' ' ' ILE . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 95' ' ' LEU . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.1 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 52' ' ' LYS . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.427 ' CG1' HD11 ' A' ' 42' ' ' ILE . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 2.8 p-10 -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 44' ' ' VAL . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.859 HD13 HG21 ' A' ' 82' ' ' THR . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.859 HG21 HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 23' ' ' LEU . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 114' ' ' LEU . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.722 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 128' ' ' ILE . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.722 HD13 ' CZ ' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.444 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 23' ' ' LEU 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 76' ' ' MET . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG11 HG23 ' A' ' 74' ' ' VAL . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 27' ' ' GLN . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HB ' HD12 ' A' ' 10' ' ' LEU . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 49' ' ' PHE . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.506 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 63' ' ' VAL . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 82' ' ' THR . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 25' ' ' VAL . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.432 ' HG2' HD21 ' A' ' 20' ' ' LEU . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 95' ' ' LEU . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.515 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.477 ' H ' ' HB3' ' A' ' 123' ' ' ALA . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 116' ' ' MET . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.563 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 127' ' ' PHE . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 74' ' ' VAL . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 8' ' ' TYR 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.611 ' HB2' HG23 ' A' ' 42' ' ' ILE . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 82' ' ' THR . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 63' ' ' VAL 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' PHE . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.475 HG21 ' CG ' ' A' ' 32' ' ' LYS . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 33' ' ' ALA . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 78' ' ' ILE . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 76' ' ' MET . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 82' ' ' THR . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.63 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.531 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 113' ' ' VAL . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 104' ' ' THR 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.438 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.566 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 95' ' ' LEU . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 76' ' ' MET . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 40' ' ' TYR . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 38' ' ' VAL . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 112' ' ' PHE . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 42' ' ' ILE . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . 0.543 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 84' ' ' LEU . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 82' ' ' THR . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 65' ' ' GLU . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.552 HG21 HD13 ' A' ' 61' ' ' LEU . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HG ' HD22 ' A' ' 23' ' ' LEU . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' NE ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.822 ' CE1' HD13 ' A' ' 114' ' ' LEU . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.521 ' CD2' HD13 ' A' ' 42' ' ' ILE . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.822 HD13 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.441 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 129' ' ' ARG . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.474 ' N ' HG22 ' A' ' 128' ' ' ILE . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 38' ' ' VAL . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 128' ' ' ILE . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.747 HD13 HD11 ' A' ' 30' ' ' ILE . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 30' ' ' ILE . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 20' ' ' LEU . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.729 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' HD23 ' A' ' 10' ' ' LEU . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 50' ' ' THR . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.772 ' HB2' HG22 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 43' ' ' ILE . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 80' ' ' SER . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.729 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' HG23 ' A' ' 67' ' ' VAL . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 61' ' ' LEU . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 84' ' ' LEU . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' A' ' 82' ' ' THR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 114' ' ' LEU . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' HD13 ' A' ' 128' ' ' ILE . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 105' ' ' TYR . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 127' ' ' PHE . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 10' ' ' LEU . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.526 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.415 -0.216 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' CB ' HG21 ' A' ' 30' ' ' ILE . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 40' ' ' TYR . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 38' ' ' VAL . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.756 HD23 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.756 ' CG1' HD23 ' A' ' 71' ' ' LEU . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.557 ' O ' HD22 ' A' ' 71' ' ' LEU . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HB2' HD23 ' A' ' 114' ' ' LEU . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 114' ' ' LEU . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 129' ' ' ARG . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 74' ' ' VAL . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 30' ' ' ILE . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.479 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 42' ' ' ILE . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 63' ' ' VAL . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.745 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 82' ' ' THR . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 67' ' ' VAL . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 114' ' ' LEU . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.537 HD21 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 121' ' ' MET . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.476 ' H ' ' HB3' ' A' ' 118' ' ' ALA . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.537 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.508 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.428 0.156 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' H ' ' HA ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 123' ' ' ALA . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD12 HD11 ' A' ' 30' ' ' ILE . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 20' ' ' LEU . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 74' ' ' VAL . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.896 HD11 HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 10' ' ' LEU . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 51' ' ' PHE . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 42' ' ' ILE . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 63' ' ' VAL . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.865 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB3' HG13 ' A' ' 38' ' ' VAL . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 82' ' ' THR . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 49' ' ' PHE . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.662 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.865 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.444 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE3' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.537 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HA ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CG ' HD21 ' A' ' 114' ' ' LEU . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -39.95 143.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 121.536 1.971 . . . . 0.0 112.546 163.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD21 ' HG ' ' A' ' 95' ' ' LEU . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 55' ' ' SER . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 8' ' ' TYR . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 41' ' ' GLU . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 82' ' ' THR . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' HB1' ' A' ' 33' ' ' ALA . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 61' ' ' LEU . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 82' ' ' THR . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD2' HD13 ' A' ' 114' ' ' LEU . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 114' ' ' LEU . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' CYS . . . . . 0.432 ' HA ' HG12 ' A' ' 122' ' ' VAL . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 117' ' ' CYS . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.624 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.66 149.89 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.985 1.266 . . . . 0.0 111.213 163.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HD21 ' A' ' 10' ' ' LEU . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' CG ' ' HA ' ' A' ' 123' ' ' ALA . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 26' ' ' PRO . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 74' ' ' VAL . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' HD11 ' A' ' 20' ' ' LEU . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' A' ' 20' ' ' LEU . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 10' ' ' LEU . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 107' ' ' PHE . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 82' ' ' THR . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' THR 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 84' ' ' LEU . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG12 ' HB1' ' A' ' 33' ' ' ALA . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' VAL . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' A' ' 91' ' ' VAL . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HB2' HG21 ' A' ' 44' ' ' VAL . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' MET . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.648 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mtm . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -130.73 139.89 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.331 1.423 . . . . 0.0 108.62 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE1' HG23 ' A' ' 30' ' ' ILE . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 95' ' ' LEU . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.1 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 52' ' ' LYS . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' CG1' HD11 ' A' ' 42' ' ' ILE . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 2.8 p-10 -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 44' ' ' VAL . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.859 HD13 HG21 ' A' ' 82' ' ' THR . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.859 HG21 HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 23' ' ' LEU . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 114' ' ' LEU . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.722 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 128' ' ' ILE . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.722 HD13 ' CZ ' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.444 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ptm . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -161.15 128.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 121.329 1.877 . . . . 0.0 110.352 177.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 23' ' ' LEU 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.432 HD21 ' HG2' ' A' ' 76' ' ' MET . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG11 HG23 ' A' ' 74' ' ' VAL . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 27' ' ' GLN . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HB ' HD12 ' A' ' 10' ' ' LEU . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 49' ' ' PHE . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.506 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 63' ' ' VAL . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 82' ' ' THR . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 25' ' ' VAL . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.432 ' HG2' HD21 ' A' ' 20' ' ' LEU . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 95' ' ' LEU . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.515 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.477 ' H ' ' HB3' ' A' ' 123' ' ' ALA . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 116' ' ' MET . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.563 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tmm? . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.74 153.64 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.49 1.495 . . . . 0.0 111.775 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 127' ' ' PHE . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 74' ' ' VAL . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 8' ' ' TYR 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.611 ' HB2' HG23 ' A' ' 42' ' ' ILE . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 82' ' ' THR . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 63' ' ' VAL 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' PHE . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.475 HG21 ' CG ' ' A' ' 32' ' ' LYS . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 33' ' ' ALA . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 78' ' ' ILE . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 76' ' ' MET . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 82' ' ' THR . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.63 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.531 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 113' ' ' VAL . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 104' ' ' THR 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -152.92 154.99 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.645 1.111 . . . . 0.0 109.564 175.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.438 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.566 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 95' ' ' LEU . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 76' ' ' MET . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 40' ' ' TYR . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 38' ' ' VAL . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 112' ' ' PHE . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 42' ' ' ILE . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . 0.543 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 84' ' ' LEU . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 82' ' ' THR . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 65' ' ' GLU . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.552 HG21 HD13 ' A' ' 61' ' ' LEU . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HG ' HD22 ' A' ' 23' ' ' LEU . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' NE ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.822 ' CE1' HD13 ' A' ' 114' ' ' LEU . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.521 ' CD2' HD13 ' A' ' 42' ' ' ILE . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.822 HD13 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.441 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 129' ' ' ARG . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.474 ' N ' HG22 ' A' ' 128' ' ' ILE . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.507 2.421 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.85 145.08 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.492 1.917 . . . . 0.0 108.737 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 38' ' ' VAL . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 128' ' ' ILE . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.747 HD13 HD11 ' A' ' 30' ' ' ILE . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 30' ' ' ILE . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 20' ' ' LEU . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.729 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' HD23 ' A' ' 10' ' ' LEU . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 50' ' ' THR . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.772 ' HB2' HG22 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 43' ' ' ILE . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 80' ' ' SER . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.729 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' HG23 ' A' ' 67' ' ' VAL . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 61' ' ' LEU . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 84' ' ' LEU . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' A' ' 82' ' ' THR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 114' ' ' LEU . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' HD13 ' A' ' 128' ' ' ILE . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 105' ' ' TYR . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 127' ' ' PHE . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 10' ' ' LEU . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.526 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.277 14.8 ttt . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -50.43 148.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.229 0.922 . . . . 0.0 110.415 163.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' CB ' HG21 ' A' ' 30' ' ' ILE . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 40' ' ' TYR . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 38' ' ' VAL . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.756 HD23 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.756 ' CG1' HD23 ' A' ' 71' ' ' LEU . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.557 ' O ' HD22 ' A' ' 71' ' ' LEU . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HB2' HD23 ' A' ' 114' ' ' LEU . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 114' ' ' LEU . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 129' ' ' ARG . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.19 138.57 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.767 1.627 . . . . 0.0 109.105 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 74' ' ' VAL . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 30' ' ' ILE . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.479 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 42' ' ' ILE . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 63' ' ' VAL . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.745 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 82' ' ' THR . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 67' ' ' VAL . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 114' ' ' LEU . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.537 HD21 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 121' ' ' MET . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.476 ' H ' ' HB3' ' A' ' 118' ' ' ALA . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.537 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.508 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.6 ttt . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.08 151.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.707 1.594 . . . . 0.0 111.349 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' H ' ' HA ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 123' ' ' ALA . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD12 HD11 ' A' ' 30' ' ' ILE . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 20' ' ' LEU . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 74' ' ' VAL . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 3.9 pm0 -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.896 HD11 HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 10' ' ' LEU . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 51' ' ' PHE . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 42' ' ' ILE . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 63' ' ' VAL . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.865 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB3' HG13 ' A' ' 38' ' ' VAL . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 82' ' ' THR . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 49' ' ' PHE . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.662 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.865 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.444 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE3' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.537 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HA ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CG ' HD21 ' A' ' 114' ' ' LEU . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.436 HD21 ' HG ' ' A' ' 95' ' ' LEU . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 55' ' ' SER . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 8' ' ' TYR . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 41' ' ' GLU . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 82' ' ' THR . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' HB1' ' A' ' 33' ' ' ALA . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 61' ' ' LEU . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 82' ' ' THR . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD2' HD13 ' A' ' 114' ' ' LEU . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 114' ' ' LEU . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . 0.432 ' HA ' HG12 ' A' ' 122' ' ' VAL . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 117' ' ' CYS . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.624 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 111.213 0.079 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HD21 ' A' ' 10' ' ' LEU . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.442 ' CG ' ' HA ' ' A' ' 123' ' ' ALA . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 26' ' ' PRO . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 74' ' ' VAL . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' HD11 ' A' ' 20' ' ' LEU . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' A' ' 20' ' ' LEU . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 10' ' ' LEU . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 107' ' ' PHE . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 82' ' ' THR . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' THR 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 84' ' ' LEU . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.546 HG12 ' HB1' ' A' ' 33' ' ' ALA . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' VAL . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' A' ' 91' ' ' VAL . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HB2' HG21 ' A' ' 44' ' ' VAL . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' MET . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.648 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.451 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE1' HG23 ' A' ' 30' ' ' ILE . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 95' ' ' LEU . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 52' ' ' LYS . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.427 ' CG1' HD11 ' A' ' 42' ' ' ILE . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 0.3 OUTLIER -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 44' ' ' VAL . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.859 HD13 HG21 ' A' ' 82' ' ' THR . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.859 HG21 HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 23' ' ' LEU . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 114' ' ' LEU . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.722 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 128' ' ' ILE . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.722 HD13 ' CZ ' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.444 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.078 0 CA-C-O 119.045 -0.502 . . . . 0.0 110.352 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 23' ' ' LEU 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 34' ' ' ASN . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG11 HG23 ' A' ' 74' ' ' VAL . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 27' ' ' GLN . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.471 HD21 HD12 ' A' ' 20' ' ' LEU . 12.1 m120 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HB ' HD12 ' A' ' 10' ' ' LEU . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 49' ' ' PHE . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.506 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 63' ' ' VAL . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 82' ' ' THR . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 25' ' ' VAL . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.432 ' HG2' HD21 ' A' ' 20' ' ' LEU . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 95' ' ' LEU . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.515 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.477 ' H ' ' HB3' ' A' ' 123' ' ' ALA . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 116' ' ' MET . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.563 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 127' ' ' PHE . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 74' ' ' VAL . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 8' ' ' TYR 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.435 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.611 ' HB2' HG23 ' A' ' 42' ' ' ILE . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 82' ' ' THR . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 63' ' ' VAL 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' PHE . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.475 HG21 ' CG ' ' A' ' 32' ' ' LYS . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 33' ' ' ALA . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 78' ' ' ILE . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 76' ' ' MET . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 82' ' ' THR . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.63 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.63 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.531 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 113' ' ' VAL . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 104' ' ' THR 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.543 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.438 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.566 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 95' ' ' LEU . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 76' ' ' MET . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 40' ' ' TYR . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 38' ' ' VAL . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 112' ' ' PHE . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 42' ' ' ILE . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . 0.543 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HB3' HD22 ' A' ' 45' ' ' ASN . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 84' ' ' LEU . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 82' ' ' THR . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 65' ' ' GLU . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.849 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.552 HG21 HD13 ' A' ' 61' ' ' LEU . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HG ' HD22 ' A' ' 23' ' ' LEU . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' NE ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.822 ' CE1' HD13 ' A' ' 114' ' ' LEU . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.521 ' CD2' HD13 ' A' ' 42' ' ' ILE . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.822 HD13 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.441 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 129' ' ' ARG . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.474 ' N ' HG22 ' A' ' 128' ' ' ILE . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 38' ' ' VAL . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 128' ' ' ILE . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.747 HD13 HD11 ' A' ' 30' ' ' ILE . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 30' ' ' ILE . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 20' ' ' LEU . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.729 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' HD23 ' A' ' 10' ' ' LEU . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 50' ' ' THR . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.426 HD21 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.772 ' HB2' HG22 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 43' ' ' ILE . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 80' ' ' SER . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.729 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' HG23 ' A' ' 67' ' ' VAL . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 61' ' ' LEU . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 84' ' ' LEU . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' A' ' 82' ' ' THR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 114' ' ' LEU . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' HD13 ' A' ' 128' ' ' ILE . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 105' ' ' TYR . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 127' ' ' PHE . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 10' ' ' LEU . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.526 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 110.415 -0.216 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' CB ' HG21 ' A' ' 30' ' ' ILE . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 40' ' ' TYR . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 38' ' ' VAL . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.756 HD23 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.756 ' CG1' HD23 ' A' ' 71' ' ' LEU . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.557 ' O ' HD22 ' A' ' 71' ' ' LEU . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.613 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HB2' HD23 ' A' ' 114' ' ' LEU . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 114' ' ' LEU . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 129' ' ' ARG . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t . . . . . 0 N--CA 1.475 0.776 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 74' ' ' VAL . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 30' ' ' ILE . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.479 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 42' ' ' ILE . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 63' ' ' VAL . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.745 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 82' ' ' THR . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 67' ' ' VAL . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 114' ' ' LEU . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.537 HD21 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 121' ' ' MET . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.476 ' H ' ' HB3' ' A' ' 118' ' ' ALA . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.537 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.508 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t . . . . . 0 N--CA 1.483 1.185 0 CA-C-O 120.428 0.156 . . . . 0.0 111.349 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.452 ' H ' ' HA ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 123' ' ' ALA . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.519 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD12 HD11 ' A' ' 30' ' ' ILE . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 20' ' ' LEU . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 74' ' ' VAL . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.478 HE21 ' N ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.896 HD11 HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 10' ' ' LEU . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 51' ' ' PHE . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 42' ' ' ILE . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 63' ' ' VAL . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.865 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB3' HG13 ' A' ' 38' ' ' VAL . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 82' ' ' THR . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 49' ' ' PHE . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.662 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.865 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.444 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE3' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.537 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HA ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CG ' HD21 ' A' ' 114' ' ' LEU . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 ttt . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -39.95 143.83 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 CA-C-N 121.536 1.971 . . . . 0.0 112.546 163.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.43 114.46 12.93 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.536 1.934 . . . . 0.0 106.955 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 tt -109.25 -43.41 4.15 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.749 1.22 . . . . 0.0 110.717 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -150.04 -32.15 0.2 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.653 0.781 . . . . 0.0 113.037 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 129.09 -138.32 10.18 Favored Glycine 0 N--CA 1.473 1.133 0 CA-C-N 119.702 1.137 . . . . 0.0 114.175 168.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.3 t -136.86 141.55 42.8 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.58 1.152 . . . . 0.0 111.62 177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -127.73 121.66 30.87 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 125.917 1.687 . . . . 0.0 110.863 -173.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.2 mtpt -91.94 157.06 17.03 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.148 0.979 . . . . 0.0 110.335 174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 tp -67.74 121.24 15.53 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 119.358 -2.089 . . . . 0.0 111.305 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -115.44 -32.81 5.47 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.142 1.377 . . . . 0.0 113.398 171.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt -139.4 107.81 5.83 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 121.226 -0.921 . . . . 0.0 111.88 -173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -100.53 141.66 33.08 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.337 -0.852 . . . . 0.0 109.069 169.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -143.21 162.79 34.68 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 124.884 1.273 . . . . 0.0 109.424 173.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.624 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 7.8 t-20 63.09 -4.34 0.28 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.348 1.059 . . . . 0.0 113.709 159.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -49.15 -36.42 19.28 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 127.598 2.359 . . . . 0.0 110.115 158.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -57.47 -34.27 68.84 Favored 'General case' 0 C--O 1.215 -0.739 0 CA-C-O 118.133 -0.937 . . . . 0.0 111.845 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -76.52 -43.15 40.55 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 116.837 -1.554 . . . . 0.0 112.971 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.518 ' CE1' ' HG ' ' A' ' 20' ' ' LEU 0.285 2.2 p90 -64.15 -56.51 14.32 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 122.729 2.513 . . . . 0.0 110.202 169.615 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' ' CE1' ' A' ' 19' ' ' TYR . 59.6 mt -56.98 -34.62 68.27 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.648 1.113 . . . . 0.0 112.752 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.37 -44.54 71.33 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.289 1.404 . . . . 0.0 112.178 169.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.6 -34.22 17.37 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 119.772 1.169 . . . . 0.0 112.529 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.436 HD21 ' HG ' ' A' ' 95' ' ' LEU . 18.9 mt -85.2 -23.26 28.38 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.254 1.421 . . . . 0.0 113.788 177.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.57 28.69 4.73 Favored Glycine 0 N--CA 1.473 1.156 0 N-CA-C 115.901 1.12 . . . . 0.0 115.901 178.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.04 144.69 30.37 Favored Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 118.95 1.375 . . . . 0.0 110.807 174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -69.82 128.85 16.55 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.837 3.692 . . . . 0.0 112.129 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -60.95 -41.48 96.36 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 116.601 2.075 . . . . 0.0 116.601 -172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -72.58 -37.51 68.15 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 121.292 1.86 . . . . 0.0 111.313 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.6 t -69.07 -41.0 78.15 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 118.833 -0.604 . . . . 0.0 111.644 170.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -42.81 -43.53 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 126.982 2.113 . . . . 0.0 111.882 171.162 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.7 -13.6 59.73 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.734 1.213 . . . . 0.0 113.489 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -85.46 -38.17 18.93 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.145 1.378 . . . . 0.0 110.294 161.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.848 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -72.2 -50.0 30.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 127.429 2.292 . . . . 0.0 113.823 -168.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.63 29.95 6.74 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.935 1.694 . . . . 0.0 110.094 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.54 157.2 14.3 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.464 -1.398 . . . . 0.0 111.032 165.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.39 -171.94 0.81 Allowed 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.043 1.162 . . . . 0.0 111.18 163.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.41 -24.78 2.5 Favored Glycine 0 N--CA 1.468 0.818 0 O-C-N 121.214 -0.929 . . . . 0.0 112.765 -173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 ' CG1' ' HB3' ' A' ' 55' ' ' SER . 79.1 t -46.44 131.1 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.646 0.778 . . . . 0.0 109.233 159.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.77 109.05 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.682 0.753 . . . . 0.0 109.832 165.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.456 ' CD2' ' CZ ' ' A' ' 127' ' ' PHE . 40.2 m-85 -111.44 151.24 28.78 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 154.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 0.5 OUTLIER -130.38 112.04 12.9 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' THR . 0.6 OUTLIER -110.63 113.07 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 119.04 0.836 . . . . 0.0 109.064 166.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.43 131.18 41.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 169.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.453 HG22 ' CE2' ' A' ' 8' ' ' TYR . 33.7 m -135.87 121.59 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-O 123.149 1.452 . . . . 0.0 112.454 167.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -158.72 55.78 0.43 Allowed 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 112.59 -2.095 . . . . 0.0 110.195 -166.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.22 -104.86 0.59 Allowed Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.552 1.072 . . . . 0.0 112.463 171.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.06 42.79 0.07 Allowed 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -174.05 98.43 0.1 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.295 2.638 . . . . 0.0 109.061 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.31 138.3 51.51 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.617 0.767 . . . . 0.0 109.805 166.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 94.5 m -149.25 134.87 18.63 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.344 2.258 . . . . 0.0 107.317 -171.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -136.95 123.34 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.382 1.473 . . . . 0.0 109.46 169.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 41' ' ' GLU . 13.1 pttt -126.59 163.48 23.33 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 170.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 p -129.13 140.98 51.32 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.949 2.5 . . . . 0.0 108.697 168.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.5 t -132.28 24.43 4.49 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.755 1.622 . . . . 0.0 110.518 -174.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' ' CG1' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -70.44 20.05 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 128.697 2.799 . . . . 0.0 115.133 -171.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.24 -27.84 8.73 Favored Glycine 0 N--CA 1.468 0.825 0 C-N-CA 124.921 1.248 . . . . 0.0 112.055 -163.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -102.99 136.69 42.34 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.368 1.467 . . . . 0.0 109.422 168.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -92.74 72.19 4.92 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.211 1.004 . . . . 0.0 110.441 178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 m -108.43 122.9 47.97 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.604 0.762 . . . . 0.0 111.786 -169.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -149.08 123.8 9.86 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 121.19 -0.944 . . . . 0.0 110.495 -165.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.548 HD13 HG21 ' A' ' 82' ' ' THR . 3.1 pp -137.5 168.76 19.0 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.891 1.277 . . . . 0.0 111.98 -175.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.9 pt -125.02 -160.72 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.727 1.211 . . . . 0.0 112.104 -174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.1 t -60.25 131.09 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.258 1.823 . . . . 0.0 108.85 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 47.66 71.1 0.36 Allowed 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 119.044 0.838 . . . . 0.0 112.864 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -143.16 -165.56 2.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.248 1.019 . . . . 0.0 112.439 -179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 74.3 tt0 -137.97 160.43 39.36 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.016 1.326 . . . . 0.0 108.952 172.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.465 ' HB ' HD23 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -155.87 154.68 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.153 1.381 . . . . 0.0 110.491 170.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -114.48 151.78 32.71 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.847 1.259 . . . . 0.0 110.564 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -158.94 124.51 4.34 Favored 'General case' 0 C--O 1.236 0.346 0 O-C-N 121.381 -0.824 . . . . 0.0 111.715 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.4 p -106.33 139.05 28.97 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 125.831 1.652 . . . . 0.0 110.577 171.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.01 144.05 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.321 0.964 . . . . 0.0 111.369 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.0 -60.92 4.25 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 124.198 0.904 . . . . 0.0 113.657 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -56.68 -32.28 65.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 126.029 1.732 . . . . 0.0 113.081 173.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.848 HG22 ' HB1' ' A' ' 33' ' ' ALA . 1.3 t -83.26 -13.52 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 118.449 0.568 . . . . 0.0 110.809 177.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.18 30.12 0.6 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.858 1.663 . . . . 0.0 114.66 -173.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.28 134.97 44.59 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 125.153 1.381 . . . . 0.0 111.068 -166.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -126.53 102.35 7.07 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 126.916 2.086 . . . . 0.0 109.321 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -138.08 163.83 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.466 0.706 . . . . 0.0 109.903 -165.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -125.87 159.94 31.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.968 0.889 . . . . 0.0 111.818 -177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.5 m -147.63 119.48 8.13 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 123.287 0.635 . . . . 0.0 110.345 -167.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' O ' ' HE2' ' A' ' 83' ' ' LYS . 2.4 t80 -110.77 98.39 7.56 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.184 1.394 . . . . 0.0 109.573 -175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 HG21 HD13 ' A' ' 61' ' ' LEU . 2.5 p -74.57 154.66 38.5 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.842 1.257 . . . . 0.0 111.968 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -165.12 142.3 5.91 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 125.119 1.368 . . . . 0.0 111.231 -176.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.15 109.43 21.26 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 121.815 -0.553 . . . . 0.0 111.402 -168.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -99.62 49.58 0.93 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.542 1.537 . . . . 0.0 109.809 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.48 -99.8 1.36 Allowed Glycine 0 C--N 1.337 0.634 0 C-N-CA 125.353 1.454 . . . . 0.0 113.597 171.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 60.2 p -96.33 32.78 1.9 Allowed 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 122.121 0.962 . . . . 0.0 112.423 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.77 145.66 17.35 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 126.626 1.97 . . . . 0.0 109.522 162.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.4 tt -92.79 157.02 16.63 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 120.82 -1.175 . . . . 0.0 108.468 169.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 45.0 t -127.95 151.71 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 C-N-CA 125.928 1.691 . . . . 0.0 107.886 172.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG1' HG22 ' A' ' 82' ' ' THR . 1.0 OUTLIER -137.67 116.45 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 120.495 1.498 . . . . 0.0 109.918 166.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 42.7 t-20 -71.24 106.38 3.79 Favored 'General case' 0 CA--C 1.538 0.504 0 O-C-N 120.51 -1.369 . . . . 0.0 108.532 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.47 107.62 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.423 -0.798 . . . . 0.0 108.912 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -90.7 134.27 34.54 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.771 0.796 . . . . 0.0 109.899 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.436 ' HG ' HD21 ' A' ' 23' ' ' LEU . 1.7 mm? -113.46 104.56 55.44 Favored Pre-proline 0 CA--C 1.549 0.941 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -65.7 -9.8 24.15 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 124.54 3.493 . . . . 0.0 115.54 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -71.13 -16.78 62.57 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.517 1.927 . . . . 0.0 113.098 173.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 129.74 -40.96 1.6 Allowed Glycine 0 C--N 1.341 0.834 0 C-N-CA 126.27 1.89 . . . . 0.0 113.958 174.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.24 66.07 9.53 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 122.67 1.224 . . . . 0.0 111.127 -174.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -61.16 158.46 13.87 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.805 1.642 . . . . 0.0 112.398 174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -158.41 -161.95 11.45 Favored Glycine 0 N--CA 1.479 1.548 0 O-C-N 121.089 -1.007 . . . . 0.0 113.721 176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.2 p -133.42 124.83 27.8 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 118.679 1.24 . . . . 0.0 111.571 175.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HD2' HD13 ' A' ' 114' ' ' LEU . 29.0 mtm180 -87.52 150.81 23.49 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.74 1.616 . . . . 0.0 110.381 165.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.7 t -137.91 148.04 44.94 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 127.797 2.439 . . . . 0.0 109.991 172.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 114' ' ' LEU . 19.0 m-85 -130.63 99.41 4.96 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.78 2.032 . . . . 0.0 111.593 -168.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -75.33 142.69 43.17 Favored 'General case' 0 N--CA 1.47 0.572 0 O-C-N 121.216 -0.928 . . . . 0.0 112.601 -176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -87.69 114.65 24.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.279 1.032 . . . . 0.0 111.303 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.11 140.94 19.14 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.591 1.956 . . . . 0.0 109.718 172.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -71.21 -45.85 62.46 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.493 1.117 . . . . 0.0 113.56 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.6 tttm -75.7 11.6 1.3 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.003 1.321 . . . . 0.0 112.315 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.55 113.18 0.41 Allowed Glycine 0 C--N 1.337 0.628 0 O-C-N 120.965 -1.085 . . . . 0.0 114.693 -177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.85 146.22 40.01 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 124.349 1.059 . . . . 0.0 109.192 156.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.31 125.62 43.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.482 HD13 ' HD2' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -102.05 101.49 11.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.622 1.169 . . . . 0.0 109.331 173.794 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 11.6 t -106.65 137.9 43.81 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 119.69 1.132 . . . . 0.0 109.997 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 3.2 ptp -108.08 142.93 37.53 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 118.76 0.709 . . . . 0.0 110.546 156.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . 0.432 ' HA ' HG12 ' A' ' 122' ' ' VAL . 22.1 p -130.02 117.31 19.83 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 121.41 0.624 . . . . 0.0 112.519 167.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -113.31 163.56 14.68 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.555 1.542 . . . . 0.0 110.696 170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.45 -9.34 68.45 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-N 115.647 -0.706 . . . . 0.0 113.577 175.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -99.44 -23.42 15.13 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.962 2.105 . . . . 0.0 113.312 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 170.71 168.75 0.07 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 127.898 2.479 . . . . 0.0 111.832 -174.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.432 HG12 ' HA ' ' A' ' 117' ' ' CYS . 35.4 m -127.75 169.1 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 119.998 -1.689 . . . . 0.0 112.89 178.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -164.35 115.25 1.26 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 174.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.624 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -127.28 126.92 43.51 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 118.302 2.704 . . . . 0.0 118.302 -173.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.43 127.19 16.23 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.406 1.482 . . . . 0.0 111.615 -166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -118.97 125.4 49.31 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 -165.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 40' ' ' TYR . 7.5 m-30 -96.86 117.1 30.37 Favored 'General case' 0 C--O 1.221 -0.422 0 C-N-CA 126.305 1.842 . . . . 0.0 108.237 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.0 mm -106.78 151.41 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 120.688 -1.257 . . . . 0.0 109.371 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 2.5 ppt_? -42.65 143.15 0.72 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 -178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.551 1.54 . . . . 0.0 111.474 174.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.739 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -56.66 149.89 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 CA-C-N 119.985 1.266 . . . . 0.0 111.213 163.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -141.47 103.03 4.32 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.146 0.978 . . . . 0.0 109.301 174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 tt -86.26 -47.31 9.53 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 121.231 -0.918 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.72 -59.27 0.76 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.492 0.717 . . . . 0.0 112.29 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 151.33 -133.11 4.09 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 118.19 0.45 . . . . 0.0 112.846 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 24.4 m -150.67 144.76 25.41 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 127.233 2.213 . . . . 0.0 108.56 -177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -133.32 143.57 49.1 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.189 1.395 . . . . 0.0 111.774 -179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -123.81 162.6 22.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.189 1.796 . . . . 0.0 110.472 173.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.648 HD23 ' CD2' ' A' ' 127' ' ' PHE . 2.4 tm? -57.91 135.77 56.94 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 120.577 -1.327 . . . . 0.0 111.124 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.421 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 8.6 mm-40 -110.8 -66.86 1.04 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 125.115 1.366 . . . . 0.0 108.987 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.7 151.44 51.63 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.411 ' OD1' HD21 ' A' ' 10' ' ' LEU . 5.5 m-20 -116.95 127.65 54.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 118.556 -0.735 . . . . 0.0 109.717 166.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.78 170.69 9.22 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.255 1.822 . . . . 0.0 110.852 173.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.442 ' CG ' ' HA ' ' A' ' 123' ' ' ALA . 7.1 t-20 58.99 9.56 1.27 Allowed 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -39.95 -36.79 0.5 Allowed 'General case' 0 C--O 1.214 -0.772 0 CA-C-O 116.617 -1.658 . . . . 0.0 110.797 157.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -70.78 -10.18 58.97 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 117.044 2.238 . . . . 0.0 117.044 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -60.26 2.09 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 121.804 2.093 . . . . 0.0 108.584 165.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -73.2 9.89 1.13 Allowed 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.902 1.228 . . . . 0.0 112.561 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD11 ' C ' ' A' ' 26' ' ' PRO . 21.1 tp -73.06 -64.08 1.05 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 127.998 2.519 . . . . 0.0 112.342 152.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -92.96 -32.17 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.312 1.845 . . . . 0.0 112.289 -164.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.27 -23.4 56.06 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-O 116.95 -1.5 . . . . 0.0 112.461 160.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.9 mt -107.87 -29.53 9.0 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 122.256 2.298 . . . . 0.0 114.047 -178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 105.44 45.71 1.3 Allowed Glycine 0 N--CA 1.473 1.158 0 C-N-CA 124.977 1.275 . . . . 0.0 114.171 177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 74' ' ' VAL . 69.4 t -113.07 155.93 43.59 Favored Pre-proline 0 CA--C 1.559 1.292 0 C-N-CA 127.036 2.134 . . . . 0.0 110.521 -177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.507 ' C ' HD11 ' A' ' 20' ' ' LEU . 5.4 Cg_exo -83.47 136.75 7.7 Favored 'Trans proline' 0 C--N 1.362 1.25 1 C-N-CA 127.29 5.327 . . . . 0.0 114.162 171.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.312 0.6 OUTLIER -61.19 -49.57 76.63 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 121.168 1.804 . . . . 0.0 112.909 -170.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -73.68 -4.7 35.99 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 120.227 1.376 . . . . 0.0 113.604 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -92.3 -36.62 13.1 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.179 1.392 . . . . 0.0 112.843 167.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.491 ' CG2' HD13 ' A' ' 20' ' ' LEU . 3.6 tt -77.2 -35.78 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 120.389 -1.444 . . . . 0.0 111.686 172.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -73.43 -19.19 61.03 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 120.943 -1.098 . . . . 0.0 112.009 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.518 ' HE3' HG21 ' A' ' 73' ' ' THR . 12.7 pttt -87.17 -8.27 57.1 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 163.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -101.59 -61.39 1.39 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 120.391 -1.443 . . . . 0.0 112.853 177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -65.22 9.33 0.11 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.815 2.046 . . . . 0.0 112.201 157.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' HB2' ' HA ' ' A' ' 32' ' ' LYS . 5.4 t -53.64 129.38 54.29 Favored Pre-proline 0 C--O 1.242 0.675 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 161.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HB3' HD11 ' A' ' 10' ' ' LEU . 41.3 Cg_endo -73.12 -148.3 0.03 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 123.702 2.935 . . . . 0.0 110.576 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 75.55 -16.8 3.73 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 120.042 -1.661 . . . . 0.0 113.366 -169.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 77.7 t -42.06 127.6 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.658 1.983 . . . . 0.0 111.215 167.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.44 92.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 157.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 20.7 m-85 -93.36 140.67 29.3 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 152.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -128.5 117.42 21.29 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 119.805 1.184 . . . . 0.0 108.336 172.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -124.54 110.35 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.135 1.374 . . . . 0.0 109.137 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 21.3 pt -111.92 67.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 120.995 -1.066 . . . . 0.0 111.373 -169.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.415 HG21 ' HB2' ' A' ' 107' ' ' PHE . 6.3 m -80.86 129.96 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 CA-C-O 123.751 1.739 . . . . 0.0 113.189 -177.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -163.8 77.04 0.38 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.033 2.133 . . . . 0.0 109.572 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 49.55 -97.64 0.02 OUTLIER Glycine 0 N--CA 1.475 1.267 0 C-N-CA 126.897 2.189 . . . . 0.0 114.008 169.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -70.27 25.45 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.67 1.588 . . . . 0.0 114.14 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -165.62 104.18 0.71 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.973 1.709 . . . . 0.0 108.104 -174.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.484 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 24.0 m-85 -137.01 134.26 36.42 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 29.5 m -160.0 137.04 9.35 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 129.351 3.06 . . . . 0.0 109.877 -178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -131.06 139.06 49.85 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.532 1.933 . . . . 0.0 109.709 167.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -142.92 156.24 44.86 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.337 -0.852 . . . . 0.0 112.902 175.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -111.06 143.37 41.89 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 126.562 1.945 . . . . 0.0 109.302 162.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -133.27 12.36 4.2 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.3 1.84 . . . . 0.0 111.721 -177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.438 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.6 p -72.73 34.13 0.07 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 119.437 -2.04 . . . . 0.0 114.79 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 -26.34 24.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.044 1.307 . . . . 0.0 112.488 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 9.3 tpt -94.66 119.22 32.95 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.534 1.167 . . . . 0.0 109.396 165.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -77.41 91.74 3.9 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.292 0.637 . . . . 0.0 111.04 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.1 m -123.01 117.35 25.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 118.08 -0.962 . . . . 0.0 110.685 -174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.9 t -144.32 128.21 17.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 120.315 1.416 . . . . 0.0 109.981 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.79 HD13 HG21 ' A' ' 82' ' ' THR . 2.1 pp -134.07 128.47 34.29 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.188 1.795 . . . . 0.0 108.834 -173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 50' ' ' THR 0.286 0.2 OUTLIER -77.86 -64.56 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 120.653 -1.28 . . . . 0.0 109.907 -178.5 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.573 HG13 HD12 ' A' ' 84' ' ' LEU . 43.0 t -173.08 138.96 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 128.508 2.723 . . . . 0.0 107.499 -163.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 58.43 31.52 21.05 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -134.11 178.07 7.25 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 125.192 1.397 . . . . 0.0 110.433 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.02 162.23 23.9 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 120.644 -1.285 . . . . 0.0 112.482 178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 p -146.46 166.06 7.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 125.627 1.571 . . . . 0.0 110.457 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -121.53 156.0 33.79 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 126.419 1.888 . . . . 0.0 108.58 169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -153.95 143.57 21.67 Favored 'General case' 0 C--N 1.329 -0.302 0 O-C-N 121.029 -1.044 . . . . 0.0 110.942 165.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.6 p -101.25 145.32 11.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 C-N-CA 124.224 1.01 . . . . 0.0 110.775 166.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.67 150.1 24.34 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.916 2.086 . . . . 0.0 111.103 172.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -65.59 -83.82 0.09 OUTLIER Glycine 0 N--CA 1.473 1.133 0 C-N-CA 125.771 1.653 . . . . 0.0 114.348 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.518 HG21 ' HE3' ' A' ' 32' ' ' LYS . 28.0 m -63.09 -57.16 11.55 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.579 -0.954 . . . . 0.0 112.035 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.546 HG12 ' HB1' ' A' ' 33' ' ' ALA . 8.5 p -57.05 -17.3 5.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 124.383 1.073 . . . . 0.0 113.007 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 19.9 m120 60.13 13.67 3.98 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.577 1.151 . . . . 0.0 113.442 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.431 ' H ' HG13 ' A' ' 74' ' ' VAL . 27.6 mtp -72.07 114.54 10.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 121.084 -1.01 . . . . 0.0 109.645 -178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -100.34 105.87 17.44 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 170.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.43 162.31 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 O-C-N 121.349 -0.845 . . . . 0.0 112.0 -171.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -122.54 158.32 30.14 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.733 0.778 . . . . 0.0 112.469 179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.1 t -147.28 128.69 14.91 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 126.328 1.851 . . . . 0.0 109.349 -163.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -126.39 88.38 2.83 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 119.471 1.032 . . . . 0.0 112.631 -169.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.79 HG21 HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -76.99 135.39 38.69 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 125.996 1.718 . . . . 0.0 111.899 -167.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HE3' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -145.66 128.57 16.41 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.091 1.356 . . . . 0.0 108.47 176.483 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.573 HD12 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -87.08 144.05 27.04 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 120.49 -1.381 . . . . 0.0 110.285 176.257 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -129.97 60.96 1.59 Allowed 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.736 2.015 . . . . 0.0 107.347 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.0 -86.61 0.67 Allowed Glycine 0 CA--C 1.528 0.894 0 O-C-N 120.725 -1.235 . . . . 0.0 114.238 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.3 p -105.77 17.02 24.39 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.919 1.688 . . . . 0.0 113.79 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.9 144.79 15.04 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.895 1.278 . . . . 0.0 111.01 175.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.3 tt -101.16 146.65 27.22 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 120.574 -1.329 . . . . 0.0 108.684 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.1 p -110.76 164.58 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 125.852 1.661 . . . . 0.0 108.818 167.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.484 HG21 ' CE1' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -155.55 112.5 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.693 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -176.513 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -79.23 102.46 8.56 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.737 1.608 . . . . 0.0 108.545 -176.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.46 106.63 18.4 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 123.971 0.909 . . . . 0.0 111.388 -174.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -102.87 131.2 49.94 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 122.198 0.999 . . . . 0.0 112.574 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -109.63 110.15 59.64 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 105.298 -2.112 . . . . 0.0 105.298 179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -61.75 -16.17 47.1 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.804 2.336 . . . . 0.0 113.867 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -65.29 11.44 0.06 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 126.511 1.924 . . . . 0.0 114.418 167.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 95.28 -41.69 2.46 Favored Glycine 0 N--CA 1.465 0.597 0 C-N-CA 126.482 1.991 . . . . 0.0 113.42 173.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.07 54.09 2.66 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.474 1.51 . . . . 0.0 113.122 -170.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -71.4 163.62 27.35 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.55 1.94 . . . . 0.0 114.51 175.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.08 -154.18 7.87 Favored Glycine 0 CA--C 1.536 1.389 0 N-CA-C 115.7 1.04 . . . . 0.0 115.7 175.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 73.7 p -116.3 108.96 16.74 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.546 1.538 . . . . 0.0 112.793 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.456 ' HB3' HG23 ' A' ' 91' ' ' VAL . 2.0 mtt180 -71.98 149.94 44.54 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 120.149 -1.594 . . . . 0.0 109.524 166.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.1 t -134.91 134.26 40.46 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 127.445 2.298 . . . . 0.0 108.034 172.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 114' ' ' LEU . 7.4 m-30 -126.93 96.73 4.72 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.714 2.006 . . . . 0.0 110.734 -171.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 2.6 tm-20 -79.04 152.81 30.69 Favored 'General case' 0 N--CA 1.472 0.641 0 O-C-N 120.978 -1.076 . . . . 0.0 110.395 174.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' HB2' HG21 ' A' ' 44' ' ' VAL . 5.3 p90 -125.18 136.55 53.69 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.548 1.939 . . . . 0.0 114.52 171.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.12 153.55 33.03 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.06 3.344 . . . . 0.0 108.886 172.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -54.81 -40.82 69.9 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 119.92 1.236 . . . . 0.0 112.486 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.9 -8.5 44.76 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 170.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.34 143.12 3.58 Favored Glycine 0 C--O 1.223 -0.556 0 CA-C-N 121.027 1.74 . . . . 0.0 116.126 177.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.476 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.0 t80 -89.97 142.49 27.66 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 126.616 1.966 . . . . 0.0 107.977 155.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.92 101.71 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 120.076 1.307 . . . . 0.0 112.951 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.495 ' HA ' ' CD1' ' A' ' 105' ' ' TYR . 0.8 OUTLIER -67.98 101.83 1.18 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 129.673 3.189 . . . . 0.0 111.748 175.684 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.0 m -122.79 113.98 19.91 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-O 118.192 -0.909 . . . . 0.0 112.986 -173.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 123' ' ' ALA . 0.0 OUTLIER -89.32 91.34 8.71 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.806 1.242 . . . . 0.0 109.018 179.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.19 140.12 32.75 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.473 0.709 . . . . 0.0 110.042 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.46 171.28 14.3 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.964 1.706 . . . . 0.0 109.636 170.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.0 -11.23 85.41 Favored Glycine 0 CA--C 1.534 1.267 0 O-C-N 121.345 -0.847 . . . . 0.0 112.927 165.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -93.81 -36.27 12.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.726 1.611 . . . . 0.0 111.589 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 2.3 mmt -159.53 -175.49 5.21 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.947 1.699 . . . . 0.0 111.294 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.2 m -152.77 134.85 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.098 1.359 . . . . 0.0 109.74 174.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 116' ' ' MET . . . -114.6 157.61 22.83 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 125.534 1.534 . . . . 0.0 114.589 -178.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.413 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.7 OUTLIER -150.09 121.24 7.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.309 1.044 . . . . 0.0 110.534 -168.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.16 165.37 27.63 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.497 2.319 . . . . 0.0 106.883 174.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -161.19 145.56 13.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 115.859 1.799 . . . . 0.0 115.859 -168.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.648 ' CD2' HD23 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -127.5 118.28 23.69 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.81 2.044 . . . . 0.0 107.219 -167.296 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.421 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 18.2 mt -119.9 160.44 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 119.938 1.244 . . . . 0.0 108.962 -177.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 1.4 ppt_? -39.48 142.89 0.24 Allowed 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 116.085 1.883 . . . . 0.0 116.085 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.038 1.735 . . . . 0.0 111.139 170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.9 mtm . . . . . 0 N--CA 1.505 2.303 0 CA-C-O 118.05 -0.976 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -130.73 139.89 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.331 1.423 . . . . 0.0 108.62 174.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 27.4 tp60 -136.02 121.95 20.01 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.721 0.808 . . . . 0.0 109.304 169.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.9 tt -100.45 -63.12 1.16 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.162 1.385 . . . . 0.0 107.741 169.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -118.61 -93.58 0.51 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.921 1.689 . . . . 0.0 109.401 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.14 -152.22 10.96 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 125.219 1.39 . . . . 0.0 111.228 -162.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 82.0 m -124.67 133.93 53.05 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 124.283 1.033 . . . . 0.0 108.831 172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -106.28 136.93 45.13 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.928 1.291 . . . . 0.0 111.215 177.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -90.66 -178.96 5.42 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 122.783 0.433 . . . . 0.0 110.157 163.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 1.1 tm? -59.89 137.2 58.13 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 120.822 -1.174 . . . . 0.0 110.48 162.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -103.61 -69.71 0.79 Allowed 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.773 1.229 . . . . 0.0 107.726 155.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.5 mmmt -134.2 161.32 35.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 111.948 -161.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.444 ' HA ' ' CB ' ' A' ' 125' ' ' ARG . 0.5 OUTLIER -131.24 135.03 47.0 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.017 -0.992 . . . . 0.0 108.986 163.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -138.75 158.01 45.03 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.108 1.763 . . . . 0.0 108.976 173.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.451 ' HB3' ' H ' ' A' ' 124' ' ' LYS . 1.4 t-20 64.06 -0.35 0.85 Allowed 'General case' 0 CA--C 1.563 1.447 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 157.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.555 ' CE1' HG23 ' A' ' 30' ' ' ILE . 46.5 p90 -60.4 -23.17 64.14 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 128.621 2.768 . . . . 0.0 110.643 158.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . 0.261 16.5 pt-20 -57.35 -45.36 84.43 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 124.379 1.05 . . . . 0.0 109.578 172.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -59.21 -21.93 60.26 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -84.56 -70.81 0.55 Allowed 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 120.414 1.461 . . . . 0.0 109.701 167.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.3 mt -49.3 -36.57 21.32 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 124.05 0.844 . . . . 0.0 111.901 -174.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.73 -31.17 41.05 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 120.625 1.557 . . . . 0.0 113.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.48 -32.3 72.3 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 119.514 1.052 . . . . 0.0 111.601 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.432 HD21 ' HG ' ' A' ' 95' ' ' LEU . 1.4 mt -77.62 -11.22 59.84 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.859 0.864 . . . . 0.0 112.241 169.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.95 14.12 27.54 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 117.552 1.781 . . . . 0.0 117.552 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 44.3 t -83.9 141.9 41.39 Favored Pre-proline 0 CA--C 1.556 1.195 0 CA-C-N 119.405 1.603 . . . . 0.0 111.641 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_exo -68.97 133.84 28.08 Favored 'Trans proline' 0 C--N 1.359 1.084 0 C-N-CA 124.485 3.457 . . . . 0.0 113.708 -177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . 0.3 0.0 OUTLIER -58.38 -48.02 81.96 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 -173.424 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -27.1 67.28 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 120.032 -1.668 . . . . 0.0 113.808 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.75 -24.88 41.26 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.617 1.567 . . . . 0.0 112.986 166.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.555 HG23 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -64.97 -42.2 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 126.095 1.758 . . . . 0.0 110.186 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -73.85 -11.39 60.35 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.647 1.179 . . . . 0.0 111.772 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -88.48 -27.29 21.59 Favored 'General case' 0 CA--C 1.551 0.986 0 O-C-N 120.64 -1.287 . . . . 0.0 111.778 161.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.4 -54.36 7.18 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.462 1.505 . . . . 0.0 112.884 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.1 m-80 -91.1 33.81 0.95 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.148 1.379 . . . . 0.0 109.99 166.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p -55.01 139.13 64.26 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 119.91 -1.744 . . . . 0.0 110.885 178.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.22 173.33 11.54 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 123.008 2.472 . . . . 0.0 109.586 165.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.71 -4.58 79.27 Favored Glycine 0 N--CA 1.471 0.999 0 CA-C-O 119.424 -0.653 . . . . 0.0 112.953 -167.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG11 ' CE2' ' A' ' 40' ' ' TYR . 95.0 t -62.52 138.81 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 C-N-CA 124.533 1.133 . . . . 0.0 110.168 160.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 78.4 t -75.48 105.57 4.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 126.071 1.748 . . . . 0.0 108.432 158.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.462 ' CE2' HG11 ' A' ' 38' ' ' VAL . 5.5 m-85 -119.77 93.49 4.08 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.043 0.937 . . . . 0.0 110.863 172.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' HB3' ' HG2' ' A' ' 52' ' ' LYS . 14.0 tt0 -83.9 118.14 23.79 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.749 1.159 . . . . 0.0 109.779 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 HG23 ' HB2' ' A' ' 8' ' ' TYR . 0.6 OUTLIER -116.42 98.85 7.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.028 0.931 . . . . 0.0 109.323 167.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.1 pp -80.59 118.03 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 173.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' CG1' HD11 ' A' ' 42' ' ' ILE . 18.8 m -128.12 125.91 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 CA-C-O 124.023 1.868 . . . . 0.0 112.109 170.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . 0.257 0.3 OUTLIER -164.6 63.11 0.14 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 127.245 2.218 . . . . 0.0 109.617 -170.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.48 -98.09 0.31 Allowed Glycine 0 C--N 1.341 0.823 0 C-N-CA 125.378 1.466 . . . . 0.0 112.22 167.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -71.81 4.37 3.35 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.174 0.989 . . . . 0.0 113.171 175.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -137.6 111.76 8.48 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.395 1.878 . . . . 0.0 109.453 -179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 44' ' ' VAL . 10.3 m-85 -130.05 126.61 38.08 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.293 1.837 . . . . 0.0 106.428 168.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 42' ' ' ILE . 6.9 m -145.59 131.72 19.39 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.488 1.515 . . . . 0.0 109.284 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.605 ' CE1' HD13 ' A' ' 89' ' ' LEU . 0.8 OUTLIER -124.25 134.65 53.19 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.248 1.819 . . . . 0.0 108.305 -176.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.413 ' HG2' ' HB3' ' A' ' 41' ' ' GLU . 13.0 pttt -149.85 140.8 22.87 Favored 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.321 -0.862 . . . . 0.0 113.098 -175.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.74 127.72 53.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.25 1.82 . . . . 0.0 107.403 172.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 t -116.93 16.08 15.15 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.077 0.941 . . . . 0.0 112.01 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.29 20.1 0.09 Allowed 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.363 2.665 . . . . 0.0 115.455 -171.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.73 -35.88 4.2 Favored Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.992 1.758 . . . . 0.0 111.883 -175.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.9 tpt -74.48 133.47 42.35 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 154.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.44 58.09 1.72 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.71 1.204 . . . . 0.0 111.867 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.5 m -91.74 128.9 37.76 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.779 -1.201 . . . . 0.0 112.061 -171.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.8 t -146.44 143.77 29.22 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.801 0.841 . . . . 0.0 110.526 169.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.859 HD13 HG21 ' A' ' 82' ' ' THR . 4.5 pp -139.52 146.75 40.32 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.446 1.899 . . . . 0.0 109.203 178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 pt -103.13 -170.81 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 121.294 -0.879 . . . . 0.0 110.687 172.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.2 t -43.24 123.19 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 126.821 2.048 . . . . 0.0 112.428 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 62.28 28.79 17.16 Favored 'General case' 0 CA--C 1.559 1.299 0 N-CA-C 115.178 1.548 . . . . 0.0 115.178 170.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -104.5 -140.91 0.36 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.327 1.451 . . . . 0.0 112.532 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -171.78 161.14 5.85 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.031 2.132 . . . . 0.0 109.558 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.9 161.29 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.027 0.931 . . . . 0.0 111.915 178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -117.0 135.89 53.35 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.369 1.868 . . . . 0.0 110.926 170.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -133.08 163.15 29.88 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.573 0.749 . . . . 0.0 111.552 174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 m -123.33 138.21 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 124.529 1.132 . . . . 0.0 109.647 174.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.5 mt -96.33 146.2 24.95 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.85 1.26 . . . . 0.0 112.268 -175.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -59.42 -89.42 0.02 OUTLIER Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.583 1.563 . . . . 0.0 115.005 -173.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.6 m -62.13 -42.43 99.23 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.659 1.355 . . . . 0.0 114.659 -173.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.6 -21.17 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 125.594 1.558 . . . . 0.0 113.654 -177.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 4.4 m120 65.99 12.84 8.72 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.757 1.623 . . . . 0.0 115.18 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 4.6 ttm -96.85 138.48 34.33 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.492 1.517 . . . . 0.0 113.118 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.48 128.83 38.47 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.15 2.18 . . . . 0.0 110.104 174.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.5 pp -132.58 141.5 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-N 119.371 0.987 . . . . 0.0 110.733 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.43 160.94 14.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.581 0.752 . . . . 0.0 111.814 175.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 49.0 m -149.27 119.2 7.12 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.188 1.395 . . . . 0.0 110.898 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -110.89 108.73 18.62 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 123.282 0.633 . . . . 0.0 112.309 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.859 HG21 HD13 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -91.73 145.18 24.79 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-O 123.059 1.409 . . . . 0.0 111.965 -165.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.01 117.0 4.48 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.964 1.306 . . . . 0.0 108.996 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tp -82.01 142.84 32.02 Favored 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 124.65 1.18 . . . . 0.0 109.835 174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -124.29 38.81 4.11 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 0.0 109.243 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 85.6 -120.99 5.51 Favored Glycine 0 C--N 1.341 0.846 0 C-N-CA 125.744 1.64 . . . . 0.0 111.063 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 3.9 t -75.58 43.87 0.26 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.226 1.01 . . . . 0.0 113.277 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.31 145.57 0.35 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 127.648 2.379 . . . . 0.0 112.413 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.605 HD13 ' CE1' ' A' ' 51' ' ' PHE . 0.5 OUTLIER -114.36 156.18 24.91 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 121.517 -0.74 . . . . 0.0 111.113 175.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 21.2 t -129.09 147.09 33.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 C-N-CA 126.103 1.761 . . . . 0.0 107.709 167.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.488 HG13 ' CE1' ' A' ' 105' ' ' TYR . 1.4 m -132.07 117.96 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.503 1.047 . . . . 0.0 109.299 164.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -73.08 101.61 3.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 121.149 -0.969 . . . . 0.0 108.72 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.51 117.09 22.26 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 121.354 -0.842 . . . . 0.0 110.512 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -98.01 140.7 31.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 122.714 1.245 . . . . 0.0 111.413 173.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.432 ' HG ' HD21 ' A' ' 23' ' ' LEU . 2.8 mm? -113.51 100.69 52.46 Favored Pre-proline 0 N--CA 1.444 -0.738 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.24 177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 0.6 OUTLIER -36.35 -31.72 0.1 Allowed 'Trans proline' 0 N--CA 1.455 -0.736 1 C-N-CA 126.077 4.518 . . . . 0.0 117.931 172.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -59.97 -11.7 6.3 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 112.75 -3.57 26.01 Favored Glycine 0 N--CA 1.474 1.202 0 C-N-CA 125.466 1.508 . . . . 0.0 114.742 174.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.71 54.59 0.81 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.71 2.004 . . . . 0.0 112.254 -177.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.69 160.21 12.03 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 120.401 -1.437 . . . . 0.0 114.362 172.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -149.8 -143.37 3.74 Favored Glycine 0 N--CA 1.475 1.262 0 O-C-N 120.835 -1.166 . . . . 0.0 112.569 172.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.8 p -139.58 126.8 21.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.708 0.803 . . . . 0.0 112.008 174.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.631 ' CD ' HD11 ' A' ' 114' ' ' LEU . 5.3 mtt180 -90.19 147.24 23.69 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.121 1.368 . . . . 0.0 109.731 168.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.518 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 14.9 t -139.61 145.35 38.43 Favored 'General case' 0 CA--C 1.512 -0.513 0 C-N-CA 127.367 2.267 . . . . 0.0 109.301 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.722 ' CZ ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -134.46 103.38 5.67 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.987 1.315 . . . . 0.0 108.547 -171.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.55 122.7 12.92 Favored 'General case' 0 N--CA 1.466 0.363 0 O-C-N 122.04 -0.413 . . . . 0.0 111.495 -172.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 179.92 -170.58 0.15 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.919 2.087 . . . . 0.0 111.231 -178.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 7.0 m -114.92 -170.68 1.8 Allowed 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.592 1.557 . . . . 0.0 111.417 177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -53.37 -21.98 6.7 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -82.24 13.46 3.49 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 171.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 128' ' ' ILE . . . 162.9 -160.04 32.49 Favored Glycine 0 C--O 1.215 -1.04 0 O-C-N 120.226 -1.546 . . . . 0.0 116.713 173.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CD2' ' HB3' ' A' ' 105' ' ' TYR . 0.1 OUTLIER -179.57 99.95 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 127.288 2.235 . . . . 0.0 108.78 -179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.4 t -88.14 104.04 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.722 HD13 ' CZ ' ' A' ' 105' ' ' TYR . 22.7 tp -69.81 90.45 0.6 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.16 2.184 . . . . 0.0 109.999 167.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.5 m -102.22 131.73 48.58 Favored 'General case' 0 C--O 1.216 -0.698 0 C-N-CA 125.822 1.649 . . . . 0.0 110.607 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 14.6 ttt -101.23 151.87 21.35 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 119.752 1.16 . . . . 0.0 110.992 173.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 5.7 t -137.18 149.24 47.11 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.573 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -161.8 174.23 13.48 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 129.081 2.952 . . . . 0.0 108.828 -178.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.77 -34.74 52.67 Favored Glycine 0 N--CA 1.477 1.393 0 O-C-N 121.036 -1.04 . . . . 0.0 112.986 176.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -82.82 -35.6 26.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.227 1.811 . . . . 0.0 111.833 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 -176.9 5.85 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.953 1.834 . . . . 0.0 115.953 -172.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 4.5 m -143.99 162.62 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 126.748 2.019 . . . . 0.0 111.553 176.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -128.26 164.26 22.96 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.724 2.009 . . . . 0.0 111.372 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.451 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.2 OUTLIER -153.09 124.62 7.69 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.393 1.877 . . . . 0.0 109.376 174.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.444 ' CB ' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -148.54 136.06 20.51 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 120.646 -1.284 . . . . 0.0 109.001 178.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . 0.254 14.3 p90 -116.91 139.19 50.93 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -167.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -101.15 136.35 41.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 127.233 2.213 . . . . 0.0 108.347 170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' ' HA2' ' A' ' 111' ' ' GLY . 12.4 mt -139.67 151.51 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 CA-C-N 121.493 1.951 . . . . 0.0 111.695 177.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -44.36 145.75 0.78 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.74 1.616 . . . . 0.0 115.184 -169.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.096 0 C-N-CA 126.454 1.902 . . . . 0.0 114.153 -172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 ptm . . . . . 0 N--CA 1.503 2.203 0 N-CA-C 117.858 2.54 . . . . 0.0 117.858 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.506 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.4 OUTLIER -161.15 128.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 121.329 1.877 . . . . 0.0 110.352 177.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -125.85 86.32 2.52 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 118.531 0.605 . . . . 0.0 112.152 -167.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tt -71.81 -74.25 0.16 Allowed 'General case' 0 N--CA 1.466 0.369 0 O-C-N 121.789 -0.57 . . . . 0.0 110.109 172.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.78 -82.3 0.58 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.831 0.853 . . . . 0.0 111.222 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 167.49 -138.66 5.28 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 125.386 1.47 . . . . 0.0 112.304 -177.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.5 t -122.15 161.62 22.81 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 123.672 0.789 . . . . 0.0 111.254 165.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.2 OUTLIER -131.97 120.58 22.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.14 2.176 . . . . 0.0 110.853 173.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -87.84 177.54 6.96 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.212 1.005 . . . . 0.0 110.226 166.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.545 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.3 OUTLIER -74.15 128.79 36.44 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 118.527 -2.608 . . . . 0.0 110.881 178.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -98.78 -71.13 0.7 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.684 1.194 . . . . 0.0 110.853 162.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.4 mmmm -132.13 168.05 18.67 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 124.035 1.874 . . . . 0.0 112.914 -174.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -141.99 145.52 34.54 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.343 -1.299 . . . . 0.0 107.655 169.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 125' ' ' ARG . 0.1 OUTLIER -155.33 156.3 35.22 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 126.161 1.784 . . . . 0.0 106.924 -178.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.492 ' HB3' ' H ' ' A' ' 124' ' ' LYS 0.283 6.6 t-20 63.5 -4.85 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 125.478 1.511 . . . . 0.0 113.576 162.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -52.8 -39.04 62.02 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.911 1.684 . . . . 0.0 108.43 162.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.4 pm0 -49.61 -35.59 21.47 Favored 'General case' 0 C--O 1.218 -0.573 0 C-N-CA 125.869 1.668 . . . . 0.0 114.339 170.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -72.81 -36.82 67.63 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 119.173 -2.204 . . . . 0.0 112.956 -174.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.427 ' O ' ' HG ' ' A' ' 23' ' ' LEU 0.361 16.4 p90 -74.1 -46.93 39.7 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 116.305 -1.807 . . . . 0.0 112.401 171.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.471 HD12 HD21 ' A' ' 34' ' ' ASN . 8.7 mt -55.27 -29.42 58.11 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 122.562 2.437 . . . . 0.0 111.175 172.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -75.74 -40.24 55.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 119.549 -1.969 . . . . 0.0 111.537 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -26.12 63.86 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.845 1.258 . . . . 0.0 113.766 167.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.6 OUTLIER -84.81 -41.65 15.89 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 119.137 0.881 . . . . 0.0 111.506 172.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 140.43 39.82 0.08 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 118.443 2.137 . . . . 0.0 118.443 171.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG11 HG23 ' A' ' 74' ' ' VAL . 11.3 t -106.49 139.01 19.91 Favored Pre-proline 0 N--CA 1.492 1.631 0 CA-C-N 120.795 2.297 . . . . 0.0 113.684 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -64.14 137.84 58.76 Favored 'Trans proline' 0 C--N 1.355 0.9 1 C-N-CA 125.697 4.265 . . . . 0.0 116.115 177.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.554 ' HA ' HG22 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -49.09 -46.91 45.37 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.778 1.631 . . . . 0.0 115.13 -175.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -78.79 -14.46 59.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 118.968 -2.332 . . . . 0.0 114.225 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.26 -37.05 12.89 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.825 1.25 . . . . 0.0 112.195 175.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 27' ' ' GLN . 4.3 tt -77.97 -50.71 19.22 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.337 0 C-N-CA 127.255 2.222 . . . . 0.0 110.797 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.17 -33.94 76.93 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.839 1.2 . . . . 0.0 109.641 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 12.2 pttt -76.76 -21.28 55.42 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -77.43 -40.63 42.71 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 119.536 1.062 . . . . 0.0 111.883 167.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.471 HD21 HD12 ' A' ' 20' ' ' LEU . 12.1 m120 -80.71 -10.47 59.73 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.259 1.424 . . . . 0.0 112.667 -178.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.5 t -38.79 132.65 1.08 Allowed Pre-proline 0 N--CA 1.445 -0.676 0 C-N-CA 125.315 1.446 . . . . 0.0 109.324 159.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.94 -113.87 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.211 2.607 . . . . 0.0 110.801 -172.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 72.44 -40.7 0.76 Allowed Glycine 0 CA--C 1.537 1.437 0 CA-C-O 117.868 -1.518 . . . . 0.0 114.737 -177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 ' HB ' HD12 ' A' ' 10' ' ' LEU . 98.8 t -39.41 140.95 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 127.864 2.466 . . . . 0.0 112.26 177.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 75.5 t -75.9 93.8 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 O-C-N 120.637 -1.289 . . . . 0.0 109.077 162.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.482 ' CE1' ' HB3' ' A' ' 53' ' ' SER . 27.5 m-85 -104.12 103.29 13.07 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.35 1.06 . . . . 0.0 111.06 171.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.07 115.39 30.5 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 119.883 1.22 . . . . 0.0 109.055 -177.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -119.63 104.53 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 125.109 1.364 . . . . 0.0 107.512 174.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.4 pp -93.79 120.92 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.51 HG12 ' CD2' ' A' ' 49' ' ' PHE . 27.8 m -137.06 122.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 123.473 1.606 . . . . 0.0 112.278 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -167.81 68.38 0.08 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 113.157 -1.838 . . . . 0.0 109.559 -165.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 64.59 -97.21 0.23 Allowed Glycine 0 N--CA 1.473 1.101 0 C-N-CA 126.368 1.937 . . . . 0.0 113.53 166.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.506 ' H ' HG11 ' A' ' 2' ' ' VAL . 1.3 t30 -80.38 26.49 0.37 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.769 2.027 . . . . 0.0 112.395 175.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -165.34 109.86 0.87 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.596 1.559 . . . . 0.0 109.117 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' HG22 ' A' ' 63' ' ' VAL . 13.6 m-85 -134.03 119.34 18.86 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.592 1.557 . . . . 0.0 107.305 176.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.7 m -128.01 143.43 51.08 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.991 1.717 . . . . 0.0 107.337 172.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -133.79 141.82 47.63 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.222 0.609 . . . . 0.0 109.458 165.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.4 pttt -149.79 166.61 28.93 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.482 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 5.3 p -138.03 147.91 44.6 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 126.755 2.022 . . . . 0.0 111.633 170.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -138.04 30.06 2.5 Favored 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 38' ' ' VAL . 4.0 p -77.76 44.55 0.46 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.923 1.689 . . . . 0.0 113.446 177.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.28 -32.96 3.72 Favored Glycine 0 CA--C 1.528 0.878 0 O-C-N 121.095 -1.003 . . . . 0.0 112.788 -175.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.8 tpt -75.09 126.43 31.0 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 151.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -91.89 103.6 16.12 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 164.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.1 m -132.11 117.82 18.81 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 10.5 t -136.8 130.0 31.21 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.418 1.087 . . . . 0.0 110.139 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.515 HD13 HG21 ' A' ' 82' ' ' THR . 3.8 pp -139.98 159.51 42.02 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.919 2.087 . . . . 0.0 109.858 -169.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.0 pt -125.86 -172.42 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.63 -1.294 . . . . 0.0 110.677 -178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.2 OUTLIER -49.36 124.82 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.036 1.334 . . . . 0.0 112.407 -178.573 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 59.1 46.17 13.6 Favored 'General case' 0 CA--C 1.559 1.296 0 C-N-CA 124.768 1.227 . . . . 0.0 114.082 175.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -128.11 170.08 13.35 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 125.412 1.485 . . . . 0.0 114.082 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.04 157.76 27.17 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.07 1.348 . . . . 0.0 112.668 -177.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -155.08 160.54 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.754 1.221 . . . . 0.0 112.356 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -106.68 152.98 23.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.035 1.334 . . . . 0.0 111.592 164.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -158.37 142.37 15.61 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.804 1.242 . . . . 0.0 111.432 172.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 p -104.29 145.32 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 126.001 1.72 . . . . 0.0 112.846 170.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mp -92.01 154.06 19.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.405 1.482 . . . . 0.0 112.741 170.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -73.48 -56.76 5.39 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.374 1.464 . . . . 0.0 115.644 -170.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.459 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 4.3 m -82.73 -47.73 11.65 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.787 1.294 . . . . 0.0 112.514 -175.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.574 HG23 HG11 ' A' ' 25' ' ' VAL . 9.8 p -72.95 -16.06 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.493 1.517 . . . . 0.0 113.283 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.3 m120 61.34 6.49 1.41 Allowed 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.432 ' HG2' HD21 ' A' ' 20' ' ' LEU . 47.3 tpp -71.65 129.77 39.53 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 120.727 -1.233 . . . . 0.0 111.251 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.77 111.18 18.74 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 128.429 2.691 . . . . 0.0 109.051 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.406 HG21 ' CD1' ' A' ' 95' ' ' LEU . 1.1 pt -131.31 141.27 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.826 0.85 . . . . 0.0 112.006 -169.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.89 157.18 23.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 122.424 1.107 . . . . 0.0 111.906 169.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 4.8 m -145.2 123.61 12.35 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 126.922 2.089 . . . . 0.0 108.802 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -110.86 99.06 8.04 Favored 'General case' 0 N--CA 1.463 0.175 0 C-N-CA 125.006 1.322 . . . . 0.0 110.281 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.515 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 p -76.91 141.29 40.58 Favored 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 124.579 1.152 . . . . 0.0 110.455 -174.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.22 143.44 29.23 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 125.111 1.365 . . . . 0.0 111.667 172.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.71 134.86 36.84 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.662 0.785 . . . . 0.0 109.717 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -119.61 40.94 3.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.755 2.022 . . . . 0.0 109.702 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 79.3 -98.54 1.64 Allowed Glycine 0 C--N 1.34 0.775 0 C-N-CA 126.384 1.945 . . . . 0.0 110.915 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 91.8 p -89.62 30.51 1.02 Allowed 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.43 129.24 1.92 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.782 1.233 . . . . 0.0 111.758 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 tt -83.34 151.19 25.67 Favored 'General case' 0 C--O 1.224 -0.265 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 171.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 17.6 t -137.38 156.85 33.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 125.199 1.4 . . . . 0.0 107.426 176.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.482 ' CG1' HG22 ' A' ' 82' ' ' THR . 0.6 OUTLIER -146.5 123.47 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 120.172 1.351 . . . . 0.0 110.811 168.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -75.44 106.89 7.21 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.46 -0.775 . . . . 0.0 109.251 173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.65 117.62 30.42 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 123.694 0.797 . . . . 0.0 109.704 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -94.18 133.95 37.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 122.452 1.12 . . . . 0.0 110.654 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.471 ' H ' ' HG3' ' A' ' 100' ' ' LYS . 2.7 mm? -108.88 103.21 51.26 Favored Pre-proline 0 C--O 1.242 0.689 0 C-N-CA 127.173 2.189 . . . . 0.0 107.028 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -56.55 -30.37 82.55 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.035 2.49 . . . . 0.0 114.074 -173.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.84 -15.46 0.51 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.434 1.894 . . . . 0.0 114.667 173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 121.12 -16.67 9.26 Favored Glycine 0 N--CA 1.471 0.994 0 C-N-CA 125.152 1.358 . . . . 0.0 114.04 168.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.54 66.04 0.95 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.663 1.985 . . . . 0.0 111.506 -176.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.471 ' HG3' ' H ' ' A' ' 95' ' ' LEU . 0.3 OUTLIER -70.35 164.69 23.97 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -179.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -155.43 -158.11 8.6 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 123.977 0.799 . . . . 0.0 114.316 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.23 113.54 7.33 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.169 0.988 . . . . 0.0 112.612 -177.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.472 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 2.5 mtt180 -69.0 142.34 54.65 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 127.109 2.164 . . . . 0.0 109.258 165.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 5.7 t -135.47 125.88 26.67 Favored 'General case' 0 C--O 1.219 -0.537 0 C-N-CA 126.459 1.904 . . . . 0.0 108.02 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 1.3 m-85 -118.62 95.69 4.96 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 110.377 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -125.24 133.1 52.83 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.613 1.165 . . . . 0.0 109.113 -176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 175.84 -152.51 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.37 2.668 . . . . 0.0 112.578 175.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 1.3 m -155.97 -177.35 6.51 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 129.406 3.083 . . . . 0.0 109.338 176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -18.52 -47.95 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.743 3.217 . . . . 0.0 117.741 175.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -73.13 6.88 2.44 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 126.98 2.112 . . . . 0.0 114.386 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 156.04 -162.57 31.41 Favored Glycine 0 CA--C 1.53 1.03 0 CA-C-N 121.054 1.752 . . . . 0.0 117.454 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' HB2' ' CD2' ' A' ' 8' ' ' TYR . 8.6 t80 -173.02 100.86 0.13 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 125.953 1.701 . . . . 0.0 109.894 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.8 t -102.68 99.06 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-N 118.512 0.596 . . . . 0.0 109.94 -164.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.563 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -74.44 107.31 6.51 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 125.595 1.558 . . . . 0.0 109.325 173.245 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 2.4 m -111.84 118.13 34.69 Favored 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.973 1.309 . . . . 0.0 109.946 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.477 ' H ' ' HB3' ' A' ' 123' ' ' ALA . 7.1 ttp -94.68 106.34 18.32 Favored 'General case' 0 C--O 1.215 -0.723 0 CA-C-N 120.476 1.489 . . . . 0.0 109.93 173.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 7.5 m -87.46 144.02 26.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 119.075 0.852 . . . . 0.0 110.929 170.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -142.52 168.06 20.61 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 127.121 2.168 . . . . 0.0 108.806 164.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.7 -8.24 84.16 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-O 119.095 -0.836 . . . . 0.0 113.77 176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -112.12 -22.5 10.95 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.227 1.411 . . . . 0.0 112.941 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -169.56 -179.83 3.53 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.351 1.861 . . . . 0.0 112.512 175.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 10.1 m -143.66 161.57 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 124.293 1.037 . . . . 0.0 112.401 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 116' ' ' MET . . . -130.61 160.04 35.39 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 127.271 2.229 . . . . 0.0 112.545 175.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.492 ' H ' ' HB3' ' A' ' 15' ' ' ASN . 0.0 OUTLIER -159.95 103.73 1.51 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.066 2.546 . . . . 0.0 111.151 179.043 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -131.09 156.52 45.09 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 126.546 1.938 . . . . 0.0 109.752 -175.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -148.96 127.64 12.46 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.563 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 9.8 m-30 -106.38 126.92 52.84 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.967 1.707 . . . . 0.0 108.229 -176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 12.7 mt -123.38 152.08 28.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 CA-C-N 120.68 1.582 . . . . 0.0 110.317 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.535 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.4 OUTLIER -36.35 144.5 0.05 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 118.752 2.871 . . . . 0.0 118.752 -171.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.476 0.861 0 C-N-CA 127.088 2.155 . . . . 0.0 110.77 167.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 tmm? . . . . . 0 N--CA 1.5 2.03 0 CA-C-O 117.875 -1.059 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 86.9 t -61.74 153.64 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 CA-C-N 120.49 1.495 . . . . 0.0 111.775 168.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -132.61 111.98 11.66 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.534 1.534 . . . . 0.0 110.783 165.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 tt -99.41 -47.49 5.13 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 125.184 1.394 . . . . 0.0 110.474 174.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.87 -26.44 0.35 Allowed 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -172.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.55 -142.53 17.64 Favored Glycine 0 CA--C 1.525 0.682 0 CA-C-O 121.877 0.709 . . . . 0.0 112.989 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.5 m -132.17 145.76 51.57 Favored 'General case' 0 CA--C 1.51 -0.56 0 C-N-CA 126.85 2.06 . . . . 0.0 109.379 -169.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 1.5 m-85 -130.65 126.79 37.5 Favored 'General case' 0 C--O 1.22 -0.46 0 C-N-CA 125.854 1.662 . . . . 0.0 111.446 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.6 mtpp -94.96 -177.07 4.04 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.004 1.322 . . . . 0.0 110.239 165.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 127' ' ' PHE . 11.8 tp -90.73 121.93 33.04 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 118.643 -2.536 . . . . 0.0 112.511 173.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.446 ' N ' HD12 ' A' ' 10' ' ' LEU . 1.0 OUTLIER -107.09 -43.13 4.7 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.883 1.273 . . . . 0.0 113.229 167.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.7 148.68 52.6 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.381 1.446 . . . . 0.0 114.532 -177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 9.7 t-20 -139.55 137.14 35.17 Favored 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.659 -1.275 . . . . 0.0 109.119 174.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -137.42 149.19 46.72 Favored 'General case' 0 N--CA 1.474 0.739 0 O-C-N 119.896 -1.752 . . . . 0.0 109.507 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 64.35 1.32 1.24 Allowed 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.51 -1.368 . . . . 0.0 114.512 170.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.573 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 34.1 p90 -44.85 -39.23 5.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.229 1.411 . . . . 0.0 110.276 152.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -59.47 -48.27 82.28 Favored 'General case' 0 N--CA 1.443 -0.782 0 O-C-N 124.5 1.125 . . . . 0.0 110.69 174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -45.58 93.14 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 115.41 1.634 . . . . 0.0 115.41 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.573 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.262 33.0 p90 -74.06 -52.97 11.02 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 120.091 -1.631 . . . . 0.0 111.417 173.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.7 mt -53.64 -31.18 46.32 Favored 'General case' 0 CA--C 1.555 1.141 0 CA-C-N 121.377 1.899 . . . . 0.0 112.177 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.08 -41.28 50.99 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 125.46 1.504 . . . . 0.0 112.489 173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.13 -31.12 29.6 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.906 0.775 . . . . 0.0 111.817 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 21.4 mt -74.97 -48.53 23.85 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.64 1.109 . . . . 0.0 110.294 172.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 145.25 2.99 0.67 Allowed Glycine 0 N--CA 1.47 0.949 0 C-N-CA 125.057 1.313 . . . . 0.0 115.47 174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG11 HG23 ' A' ' 74' ' ' VAL . 60.7 t -70.61 141.09 87.39 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 118.533 1.166 . . . . 0.0 111.036 -172.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -72.2 140.48 34.16 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.754 3.636 . . . . 0.0 113.473 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -60.28 -55.11 37.66 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -170.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -59.61 -29.6 68.1 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 122.589 2.45 . . . . 0.0 112.22 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.3 m -77.34 -15.26 59.49 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 170.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -91.03 -42.34 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 128.984 2.914 . . . . 0.0 110.312 179.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 10.8 mtmt -84.3 -21.07 31.14 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.295 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.475 ' CG ' HG21 ' A' ' 73' ' ' THR . 0.1 OUTLIER -88.01 2.06 52.69 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-N 119.476 1.034 . . . . 0.0 113.208 160.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.551 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -96.87 -58.37 2.05 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.455 -1.403 . . . . 0.0 111.774 170.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -89.32 21.93 3.1 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.035 1.334 . . . . 0.0 111.578 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.09 134.65 30.03 Favored Pre-proline 0 N--CA 1.467 0.421 0 C-N-CA 124.469 1.108 . . . . 0.0 109.661 167.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.72 -178.0 4.19 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 123.067 2.512 . . . . 0.0 110.341 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.3 7.36 84.83 Favored Glycine 0 N--CA 1.473 1.166 0 O-C-N 121.242 -0.911 . . . . 0.0 113.026 -166.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.7 t -61.44 150.69 7.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 C-N-CA 124.26 1.024 . . . . 0.0 109.151 150.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 88.3 t -89.31 108.04 18.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 125.299 1.44 . . . . 0.0 108.346 164.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -122.66 90.06 3.23 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.241 167.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -88.94 111.95 22.73 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.451 0.569 . . . . 0.0 110.174 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.725 HG21 ' CZ ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -111.43 119.57 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 121.437 -0.789 . . . . 0.0 109.374 171.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -107.99 103.03 14.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 8' ' ' TYR 0.26 24.6 m -114.27 118.57 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 123.699 1.714 . . . . 0.0 113.35 179.461 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -152.79 56.08 0.79 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 111.906 -2.406 . . . . 0.0 110.282 -170.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 59.83 -99.78 0.17 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.297 0.951 . . . . 0.0 113.468 168.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -79.27 46.52 0.73 Allowed 'General case' 0 CA--C 1.555 1.155 0 O-C-N 121.054 -1.262 . . . . 0.0 111.605 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.82 96.78 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.599 2.36 . . . . 0.0 108.008 -175.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.435 ' HB2' ' CG2' ' A' ' 63' ' ' VAL . 25.5 m-85 -138.15 115.3 10.97 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 30.3 m -136.53 137.5 40.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.587 1.555 . . . . 0.0 107.621 173.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.611 ' HB2' HG23 ' A' ' 42' ' ' ILE . 3.4 t80 -128.87 133.09 47.82 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 123.936 0.894 . . . . 0.0 110.576 171.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 7.3 ptpt -132.22 161.78 32.58 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.7 p -129.26 137.26 50.96 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.642 2.377 . . . . 0.0 109.134 175.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.64 30.03 4.72 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.58 1.152 . . . . 0.0 111.131 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -73.34 8.08 1.92 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.494 1.517 . . . . 0.0 113.864 -176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 126.22 -31.47 4.04 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 129.222 3.296 . . . . 0.0 111.414 -175.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.9 tpt -79.33 125.59 29.7 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 159.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -89.71 64.48 6.53 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.967 0.907 . . . . 0.0 110.642 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.9 m -104.35 127.6 52.04 Favored 'General case' 0 N--CA 1.48 1.068 0 O-C-N 120.199 -1.563 . . . . 0.0 111.99 -170.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 15.3 t -131.71 131.06 42.76 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.689 1.195 . . . . 0.0 108.25 172.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 HD13 HG21 ' A' ' 82' ' ' THR . 1.9 pp -128.85 172.08 11.65 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 125.54 1.536 . . . . 0.0 110.9 -177.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.4 ' HB ' ' H ' ' A' ' 63' ' ' VAL 0.25 2.7 pp -135.21 -157.65 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 124.412 1.085 . . . . 0.0 113.091 -176.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' CG2' ' HB2' ' A' ' 49' ' ' PHE . 62.1 t -71.82 134.73 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 125.318 1.447 . . . . 0.0 112.061 -176.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.49 31.44 20.29 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.797 0.839 . . . . 0.0 112.605 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -129.87 -166.5 1.67 Allowed 'General case' 0 C--O 1.218 -0.565 0 CA-C-N 118.828 0.74 . . . . 0.0 112.621 -177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -140.23 161.66 37.12 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 120.212 -1.555 . . . . 0.0 111.896 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.33 157.76 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.843 1.257 . . . . 0.0 111.446 177.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -102.38 152.36 21.19 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.078 0.951 . . . . 0.0 110.801 161.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -155.45 149.89 26.06 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.491 171.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -106.46 161.65 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 123.607 0.763 . . . . 0.0 111.227 170.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.21 152.93 30.49 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.473 1.909 . . . . 0.0 111.087 174.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -75.03 -60.75 3.24 Favored Glycine 0 N--CA 1.473 1.124 0 N-CA-C 116.025 1.17 . . . . 0.0 116.025 -170.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.475 HG21 ' CG ' ' A' ' 32' ' ' LYS . 55.8 m -75.04 -54.2 7.57 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.277 1.039 . . . . 0.0 112.053 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.551 HG12 ' HB1' ' A' ' 33' ' ' ALA . 7.5 p -68.42 -12.89 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.709 2.003 . . . . 0.0 112.937 -178.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.9 m120 53.64 14.19 0.58 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.268 1.827 . . . . 0.0 114.54 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.437 ' HG2' HG23 ' A' ' 78' ' ' ILE . 30.1 ttm -76.39 133.13 40.0 Favored 'General case' 0 C--N 1.334 -0.07 0 O-C-N 121.075 -1.016 . . . . 0.0 111.148 -174.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -117.3 97.55 5.96 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.685 1.994 . . . . 0.0 109.19 -175.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.437 HG23 ' HG2' ' A' ' 76' ' ' MET . 2.0 pp -127.13 152.04 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 121.829 0.823 . . . . 0.0 111.89 -171.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.33 156.3 17.67 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 122.836 1.303 . . . . 0.0 112.197 -178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.9 m -145.4 119.85 9.68 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.026 1.33 . . . . 0.0 110.691 -166.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -115.2 99.7 7.61 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.084 1.353 . . . . 0.0 110.535 -177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.624 HG21 HD13 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -71.97 146.83 47.48 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.138 1.775 . . . . 0.0 110.632 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.41 128.64 3.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.812 1.245 . . . . 0.0 111.575 172.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.54 133.25 41.25 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 124.85 1.26 . . . . 0.0 110.784 -169.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -114.73 46.34 1.42 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.527 1.531 . . . . 0.0 109.44 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.0 -90.17 1.65 Allowed Glycine 0 C--N 1.339 0.727 0 C-N-CA 125.776 1.655 . . . . 0.0 113.362 174.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.44 17.14 21.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.029 0.932 . . . . 0.0 112.834 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.71 126.31 5.01 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 127.143 2.177 . . . . 0.0 108.238 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.489 HD21 ' HB ' ' A' ' 82' ' ' THR . 9.9 tt -94.59 150.06 20.62 Favored 'General case' 0 C--O 1.215 -0.737 0 O-C-N 121.051 -1.031 . . . . 0.0 108.739 173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 46.3 t -114.74 149.59 16.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 126.818 2.047 . . . . 0.0 107.649 173.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.427 HG21 ' CZ ' ' A' ' 105' ' ' TYR . 0.0 OUTLIER -136.31 102.14 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 119.695 1.134 . . . . 0.0 109.624 177.483 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -66.53 105.81 1.6 Allowed 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.099 173.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.87 126.7 41.31 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 120.875 -1.14 . . . . 0.0 109.864 177.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -107.17 135.8 48.09 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.574 174.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.63 HD11 HH22 ' A' ' 103' ' ' ARG . 2.6 mm? -116.33 106.41 48.95 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.49 -26.59 45.75 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 124.662 3.574 . . . . 0.0 114.337 -176.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -55.41 -9.63 0.5 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.108 2.563 . . . . 0.0 113.833 174.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 114.42 -24.04 11.74 Favored Glycine 0 C--N 1.338 0.685 0 C-N-CA 127.069 2.271 . . . . 0.0 113.764 168.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.21 79.76 2.36 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.664 1.586 . . . . 0.0 111.143 -172.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 162.95 28.28 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 120.489 -1.382 . . . . 0.0 112.584 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -165.03 130.97 2.28 Favored Glycine 0 N--CA 1.476 1.324 0 O-C-N 120.468 -1.395 . . . . 0.0 113.63 177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 116.55 12.39 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 119.425 1.612 . . . . 0.0 110.638 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.63 HH22 HD11 ' A' ' 95' ' ' LEU . 18.8 mtt180 -84.06 169.69 14.67 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 126.146 1.778 . . . . 0.0 110.786 165.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 13.4 t -154.58 145.69 22.77 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.061 1.744 . . . . 0.0 109.621 176.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.531 ' HB3' ' CE2' ' A' ' 112' ' ' PHE . 22.5 m-85 -121.58 103.81 9.18 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 126.835 2.054 . . . . 0.0 112.713 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' HG2' ' H ' ' A' ' 113' ' ' VAL . 6.6 pt-20 -77.29 153.0 34.31 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 121.281 -0.887 . . . . 0.0 112.178 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -104.96 109.44 21.43 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.815 0.846 . . . . 0.0 111.691 -173.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -142.45 135.91 28.94 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.538 1.135 . . . . 0.0 110.497 176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -55.78 -38.15 69.52 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.836 -1.165 . . . . 0.0 111.477 177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -81.06 3.33 23.64 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.99 2.116 . . . . 0.0 115.067 175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 161.69 151.8 6.43 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-N 120.757 1.617 . . . . 0.0 116.944 178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.725 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 2.6 t80 -119.87 103.0 8.97 Favored 'General case' 0 CA--C 1.511 -0.536 0 C-N-CA 126.432 1.893 . . . . 0.0 106.817 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 106' ' ' GLU . 36.5 t -97.24 115.73 37.71 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.596 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -169.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.775 HD11 ' CZ ' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -85.34 94.08 8.87 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.064 173.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.478 HG22 ' CG2' ' A' ' 104' ' ' THR 0.388 1.4 t -95.11 164.97 12.65 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.4 0.546 . . . . 0.0 111.311 168.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 32.7 ttp -143.94 152.16 40.73 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 128.212 2.605 . . . . 0.0 108.119 175.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 17.4 p -121.06 150.81 40.62 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.622 0.725 . . . . 0.0 111.677 162.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -133.79 -179.42 5.53 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.929 2.092 . . . . 0.0 108.003 161.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -70.54 -35.67 68.08 Favored Glycine 0 N--CA 1.476 1.363 0 O-C-N 120.428 -1.42 . . . . 0.0 111.5 168.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.38 -41.66 19.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.45 1.5 . . . . 0.0 111.806 -170.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 15.3 mmt -150.7 172.29 15.8 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.921 1.688 . . . . 0.0 112.064 -164.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.6 m -143.93 128.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.451 1.101 . . . . 0.0 109.768 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -114.12 144.53 43.01 Favored 'General case' 0 C--O 1.206 -1.205 0 CA-C-O 116.91 -1.519 . . . . 0.0 114.48 -167.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -151.65 118.32 5.74 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 121.759 2.072 . . . . 0.0 114.521 -171.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -128.5 166.18 19.28 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.99 2.116 . . . . 0.0 110.539 177.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -153.74 119.2 5.19 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 116.855 2.168 . . . . 0.0 116.855 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.775 ' CZ ' HD11 ' A' ' 114' ' ' LEU . 7.9 m-30 -99.54 120.11 39.12 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.943 1.697 . . . . 0.0 107.872 -175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.2 mt -118.85 157.25 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 O-C-N 120.323 -1.486 . . . . 0.0 110.717 -173.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -40.92 139.52 0.86 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 174.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.482 1.168 0 C-N-CA 127.675 2.39 . . . . 0.0 113.226 -178.134 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.7 ttt . . . . . 0 N--CA 1.498 1.949 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.543 HG11 ' H ' ' A' ' 47' ' ' ASN . 0.5 OUTLIER -152.92 154.99 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 119.645 1.111 . . . . 0.0 109.564 175.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 56.0 tp60 -137.61 92.5 2.69 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.272 0.487 . . . . 0.0 110.951 -177.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.0 tt -77.21 -47.66 19.64 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 123.149 0.58 . . . . 0.0 110.831 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -136.21 -78.73 0.42 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.221 1.009 . . . . 0.0 110.558 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 174.7 -124.73 1.04 Allowed Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.025 1.298 . . . . 0.0 112.172 -166.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 m -150.93 152.37 33.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.664 1.585 . . . . 0.0 109.664 173.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.477 ' CD2' ' HB2' ' A' ' 112' ' ' PHE . 2.6 m-85 -126.89 128.71 46.9 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 42.7 mttm -103.72 177.03 4.96 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.659 1.183 . . . . 0.0 110.771 169.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -62.83 148.2 47.76 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 118.953 -2.342 . . . . 0.0 111.745 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.482 ' N ' HD22 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -126.98 -67.52 0.84 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.904 1.682 . . . . 0.0 109.87 169.296 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -136.62 166.63 23.09 Favored 'General case' 0 C--O 1.234 0.279 0 O-C-N 120.457 -1.402 . . . . 0.0 111.618 -172.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -150.89 132.37 14.71 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.619 -0.676 . . . . 0.0 111.464 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -133.77 148.86 51.43 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 127.576 2.35 . . . . 0.0 107.357 -177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.438 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 26.2 m120 53.98 7.44 0.12 Allowed 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.566 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 6.7 p90 -36.22 -47.47 0.58 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 120.616 1.553 . . . . 0.0 110.529 154.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.87 -31.31 71.03 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 117.196 -1.383 . . . . 0.0 114.145 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -67.17 -52.91 35.6 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 120.696 1.589 . . . . 0.0 110.162 175.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.566 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.327 15.5 p90 -65.1 -57.37 8.79 Favored 'General case' 0 C--O 1.216 -0.7 0 C-N-CA 117.932 -1.507 . . . . 0.0 109.721 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.23 -33.0 51.08 Favored 'General case' 0 CA--C 1.555 1.171 0 CA-C-N 121.734 2.061 . . . . 0.0 113.597 -176.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.32 -31.09 27.02 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 121.431 1.923 . . . . 0.0 114.166 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -18.15 27.02 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 120.156 -1.59 . . . . 0.0 112.599 165.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD22 ' HG ' ' A' ' 95' ' ' LEU . 30.1 mt -99.96 -47.67 4.93 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.325 1.45 . . . . 0.0 110.421 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.96 38.6 0.23 Allowed Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.155 1.359 . . . . 0.0 114.911 163.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HG3' ' A' ' 76' ' ' MET . 16.3 t -92.09 143.81 28.17 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.468 1.507 . . . . 0.0 110.127 177.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.51 141.86 62.83 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.126 2.551 . . . . 0.0 112.559 -178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.2 pm0 -67.84 -38.55 83.31 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 116.611 2.078 . . . . 0.0 116.611 -166.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -80.98 -29.22 35.3 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.74 1.155 . . . . 0.0 110.901 177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.6 m -68.36 -37.22 80.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.411 1.084 . . . . 0.0 110.961 168.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.76 -40.41 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 128.332 2.653 . . . . 0.0 112.26 173.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.9 mttp -70.22 -50.67 37.52 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.459 -178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -68.46 -10.31 54.53 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 120.362 1.437 . . . . 0.0 114.873 171.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.849 ' HB1' HG22 ' A' ' 74' ' ' VAL . . . -90.05 -62.27 1.5 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.982 2.113 . . . . 0.0 113.788 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -85.31 3.74 38.26 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 114.777 -1.101 . . . . 0.0 111.389 173.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -41.89 140.35 1.48 Allowed Pre-proline 0 CA--C 1.536 0.42 0 C-N-CA 124.849 1.259 . . . . 0.0 110.123 172.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.426 ' HB3' HD21 ' A' ' 10' ' ' LEU . 39.3 Cg_endo -64.94 -168.03 0.1 Allowed 'Trans proline' 0 CA--C 1.548 1.222 0 C-N-CA 124.084 3.189 . . . . 0.0 111.522 168.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.43 -16.47 7.72 Favored Glycine 0 N--CA 1.474 1.225 0 O-C-N 119.563 -1.961 . . . . 0.0 113.875 -170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 40' ' ' TYR . 48.5 t -54.72 133.91 17.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 C-N-CA 125.148 1.379 . . . . 0.0 110.994 167.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.9 t -67.74 112.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 122.613 1.197 . . . . 0.0 109.957 160.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' CE2' HG11 ' A' ' 38' ' ' VAL . 73.7 m-85 -119.87 152.35 37.48 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 113.688 -1.596 . . . . 0.0 108.278 157.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -146.68 124.58 11.98 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 120.754 1.615 . . . . 0.0 109.584 175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.521 HD13 ' CD2' ' A' ' 112' ' ' PHE . 6.3 mt -124.33 93.76 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 C-N-CA 125.9 1.68 . . . . 0.0 109.792 -175.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.46 ' CG1' ' HB ' ' A' ' 50' ' ' THR . 31.7 pt -91.73 74.03 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 O-C-N 120.849 -1.157 . . . . 0.0 110.053 -170.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.501 HG13 HG22 ' A' ' 42' ' ' ILE . 32.8 m -92.69 123.72 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-O 123.884 1.802 . . . . 0.0 113.437 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.407 HD22 ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -159.36 69.01 0.43 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.779 1.632 . . . . 0.0 107.485 -176.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 51.05 -83.05 0.01 OUTLIER Glycine 0 N--CA 1.477 1.373 0 C-N-CA 127.2 2.333 . . . . 0.0 115.316 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . 0.543 ' H ' HG11 ' A' ' 2' ' ' VAL . 4.3 m120 -85.33 43.68 1.03 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.747 2.019 . . . . 0.0 110.746 174.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.407 ' HB3' HD22 ' A' ' 45' ' ' ASN . 4.4 mttt 175.98 111.48 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 128.71 2.804 . . . . 0.0 107.584 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' CD2' HD13 ' A' ' 84' ' ' LEU . 25.8 m-85 -141.63 120.38 12.63 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 118.807 0.73 . . . . 0.0 109.161 168.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 20.9 m -139.35 142.34 37.6 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.208 1.803 . . . . 0.0 107.76 177.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -133.61 130.03 37.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.808 1.243 . . . . 0.0 109.157 170.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 158.41 36.61 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -123.93 140.11 53.3 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 128.093 2.557 . . . . 0.0 108.835 172.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.68 28.6 5.12 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.234 1.013 . . . . 0.0 111.478 175.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.403 ' HB2' HG13 ' A' ' 38' ' ' VAL . 0.2 OUTLIER -80.73 57.78 3.09 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 120.069 -1.644 . . . . 0.0 110.721 179.358 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 77.34 -32.4 1.58 Allowed Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.756 1.17 . . . . 0.0 114.095 -178.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.7 mmt -75.9 131.36 39.61 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.644 0.722 . . . . 0.0 109.134 152.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 40.9 m-20 -89.44 98.82 11.99 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 163.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.3 m -119.8 132.02 55.48 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.629 0.772 . . . . 0.0 108.944 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -146.87 118.39 7.96 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 120.217 1.371 . . . . 0.0 109.664 172.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.552 HD13 HG21 ' A' ' 82' ' ' THR . 3.0 pp -118.49 168.68 10.44 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 125.601 1.561 . . . . 0.0 110.294 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 50' ' ' THR . 1.1 pt -129.04 -170.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 124.955 1.302 . . . . 0.0 111.201 -173.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.8 t -42.05 130.84 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 125.047 1.339 . . . . 0.0 110.109 166.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.33 29.5 p30 46.85 33.23 2.09 Favored 'General case' 0 CA--C 1.556 1.19 0 N-CA-C 118.471 2.767 . . . . 0.0 118.471 164.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.451 ' HB3' ' H ' ' A' ' 66' ' ' GLU . 44.3 mm-40 -106.91 -148.42 0.42 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 127.025 2.13 . . . . 0.0 113.218 -177.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 65' ' ' GLU . 9.7 pt-20 -160.32 157.35 27.82 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.846 2.458 . . . . 0.0 108.534 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.34 157.76 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 126.371 1.868 . . . . 0.0 110.765 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -130.55 132.46 45.58 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 123.385 0.674 . . . . 0.0 111.83 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -139.2 133.4 31.33 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.139 0.576 . . . . 0.0 111.272 -174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -118.24 127.7 75.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.274 1.43 . . . . 0.0 109.684 178.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.2 mp -112.77 145.02 41.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.04 0.536 . . . . 0.0 111.298 -171.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.95 -35.35 6.41 Favored Glycine 0 N--CA 1.469 0.887 0 CA-C-O 118.236 -1.313 . . . . 0.0 116.284 -164.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.67 -18.53 64.29 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 119.989 1.895 . . . . 0.0 113.437 171.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.849 HG22 ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.32 -24.49 4.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 130.782 3.633 . . . . 0.0 111.086 -167.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.5 m120 58.11 18.1 5.0 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.203 2.201 . . . . 0.0 114.596 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.46 ' HG3' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -119.93 130.87 55.01 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 124.473 1.109 . . . . 0.0 113.843 -165.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.34 117.41 33.94 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 127.533 2.333 . . . . 0.0 109.943 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.81 159.18 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 121.713 0.768 . . . . 0.0 112.564 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -117.57 161.14 20.1 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 122.344 1.068 . . . . 0.0 111.376 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.01 123.12 10.15 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.852 1.261 . . . . 0.0 108.493 -166.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -123.2 95.76 4.73 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.048 0.939 . . . . 0.0 110.498 -170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.552 HG21 HD13 ' A' ' 61' ' ' LEU . 1.3 p -77.94 149.07 34.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 122.672 1.225 . . . . 0.0 111.691 -170.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.76 127.78 8.96 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 124.848 1.259 . . . . 0.0 109.169 177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.451 HD13 ' CD2' ' A' ' 49' ' ' PHE . 0.3 OUTLIER -97.96 139.9 33.11 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.739 -0.601 . . . . 0.0 110.485 177.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.15 40.31 3.74 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.564 1.545 . . . . 0.0 109.315 -177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.18 -92.03 1.78 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.63 1.586 . . . . 0.0 114.211 177.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.3 p -92.63 20.4 6.42 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.773 1.287 . . . . 0.0 114.277 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.25 130.32 1.75 Allowed 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.585 1.554 . . . . 0.0 110.68 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.05 164.76 17.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 122.319 1.057 . . . . 0.0 108.407 166.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.1 t -134.7 152.12 32.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 C-N-CA 129.466 3.106 . . . . 0.0 104.739 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.1 m -139.24 130.61 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.34 1.427 . . . . 0.0 109.346 162.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -78.81 116.27 19.04 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 120.801 1.637 . . . . 0.0 110.198 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -86.49 97.18 10.34 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.554 1.542 . . . . 0.0 111.157 174.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -94.54 140.15 30.22 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 122.582 1.182 . . . . 0.0 111.502 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.648 ' HG ' HD22 ' A' ' 23' ' ' LEU . 3.0 mm? -116.87 110.8 41.52 Favored Pre-proline 0 C--O 1.241 0.63 0 C-N-CA 126.417 1.887 . . . . 0.0 108.387 176.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -47.56 -38.71 28.67 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.177 3.251 . . . . 0.0 113.851 177.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.86 -22.82 0.1 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.109 2.563 . . . . 0.0 116.131 172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 122.43 -34.36 3.83 Favored Glycine 0 N--CA 1.467 0.745 0 C-N-CA 125.12 1.343 . . . . 0.0 113.402 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.466 ' HG3' ' HA ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -82.03 58.5 3.96 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.426 1.49 . . . . 0.0 112.755 -177.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.472 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 41.7 mttp -70.15 155.77 40.15 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.983 1.313 . . . . 0.0 111.298 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -150.05 -150.95 5.4 Favored Glycine 0 N--CA 1.463 0.487 0 O-C-N 121.517 -0.739 . . . . 0.0 113.362 171.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.2 p -139.38 163.36 32.7 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.601 1.161 . . . . 0.0 111.165 -175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' NE ' HD11 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -148.74 138.95 22.37 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.807 0.843 . . . . 0.0 110.294 -169.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -117.5 128.22 54.77 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.604 1.962 . . . . 0.0 110.207 -174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.822 ' CE1' HD13 ' A' ' 114' ' ' LEU . 3.4 m-30 -121.72 79.73 1.6 Allowed 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.45 1.9 . . . . 0.0 110.321 -168.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.89 157.51 9.68 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.682 -0.636 . . . . 0.0 110.107 170.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -143.43 136.57 27.88 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.697 0.799 . . . . 0.0 111.887 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 48.6 t -165.69 146.6 6.95 Favored 'General case' 0 C--O 1.222 -0.363 0 C-N-CA 126.35 1.86 . . . . 0.0 108.593 -174.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -48.18 -44.13 32.33 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 119.916 1.235 . . . . 0.0 112.449 -176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 39.1 mttt -75.49 0.76 16.08 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.916 2.486 . . . . 0.0 114.041 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.97 150.24 5.3 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.679 1.432 . . . . 0.0 116.679 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.521 ' CD2' HD13 ' A' ' 42' ' ' ILE . 10.9 t80 -105.59 129.52 53.83 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 128.603 2.761 . . . . 0.0 107.763 167.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.2 t -116.76 119.04 60.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 118.4 0.545 . . . . 0.0 110.089 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.822 HD13 ' CE1' ' A' ' 105' ' ' TYR . 0.2 OUTLIER -100.86 103.06 14.24 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.629 2.371 . . . . 0.0 106.958 178.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.0 p -106.55 135.37 48.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 125.001 1.32 . . . . 0.0 110.677 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.441 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 1.0 OUTLIER -110.15 87.95 2.64 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 119.698 1.135 . . . . 0.0 109.987 174.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -77.07 133.86 38.93 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 173.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -116.37 -177.54 3.2 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.486 1.514 . . . . 0.0 108.304 163.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.2 -15.45 80.26 Favored Glycine 0 N--CA 1.474 1.228 0 O-C-N 121.056 -1.028 . . . . 0.0 111.293 159.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -98.23 -37.7 9.58 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.975 2.11 . . . . 0.0 111.284 -166.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 -177.73 6.7 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 128.678 2.791 . . . . 0.0 109.946 -176.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 2.6 m -144.27 166.63 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.446 0.698 . . . . 0.0 110.484 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -142.0 168.56 19.45 Favored 'General case' 0 C--O 1.224 -0.267 0 N-CA-C 115.14 1.533 . . . . 0.0 115.14 175.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.29 111.19 1.88 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 127.571 2.348 . . . . 0.0 112.86 -178.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -110.92 169.11 8.98 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 119.999 -1.688 . . . . 0.0 109.98 159.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -141.25 131.26 24.6 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.52 ' CE1' HD23 ' A' ' 10' ' ' LEU . 11.7 m-30 -109.52 125.46 52.52 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 126.608 1.963 . . . . 0.0 106.123 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 129' ' ' ARG . 19.7 mt -126.28 162.66 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.606 1.563 . . . . 0.0 110.399 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.474 ' N ' HG22 ' A' ' 128' ' ' ILE . 1.2 ptt180 -52.32 148.45 6.61 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 -176.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 128.394 2.678 . . . . 0.0 114.879 -171.99 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.4 mtm . . . . . 0 N--CA 1.507 2.421 0 N-CA-C 115.928 1.825 . . . . 0.0 115.928 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -144.85 145.08 21.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 C-N-CA 126.492 1.917 . . . . 0.0 108.737 172.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -145.58 95.96 2.74 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 121.454 0.645 . . . . 0.0 109.634 175.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.62 -46.64 6.86 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.24 0.616 . . . . 0.0 110.174 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.3 -68.73 0.57 Allowed 'General case' 0 CA--C 1.532 0.278 0 O-C-N 121.36 -0.837 . . . . 0.0 112.925 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 142.5 -136.12 7.0 Favored Glycine 0 CA--C 1.521 0.452 0 O-C-N 121.424 -0.798 . . . . 0.0 112.485 -173.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.2 m -143.36 135.93 27.36 Favored 'General case' 0 CA--C 1.495 -1.144 0 O-C-N 122.626 -0.338 . . . . 0.0 111.44 -167.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 109' ' ' ASP . 0.1 OUTLIER -120.8 130.84 54.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 125.447 1.717 . . . . 0.0 109.104 -176.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -96.9 156.06 16.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.636 0.775 . . . . 0.0 109.085 170.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.733 HD23 ' HB ' ' A' ' 38' ' ' VAL . 4.7 tp -56.21 130.75 45.65 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 119.648 -1.907 . . . . 0.0 109.378 170.024 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 128' ' ' ILE . 3.7 mt-10 -112.43 -56.41 2.4 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.346 0.658 . . . . 0.0 110.019 172.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.16 151.17 44.31 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 125.406 1.482 . . . . 0.0 113.085 -169.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' ' 125' ' ' ARG . 0.8 OUTLIER -132.47 137.48 47.24 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 121.731 -0.606 . . . . 0.0 111.758 177.569 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -136.25 152.52 50.82 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 127.084 2.153 . . . . 0.0 107.749 170.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 21.3 m120 59.67 5.12 0.63 Allowed 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 166.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.495 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 15.0 p90 -45.56 -53.94 8.32 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 155.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -55.55 -34.02 64.36 Favored 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 116.084 -1.912 . . . . 0.0 113.008 170.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -62.49 -63.01 1.36 Allowed 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 122.482 2.401 . . . . 0.0 112.218 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.495 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.275 6.7 p90 -62.25 -58.9 6.01 Favored 'General case' 0 C--O 1.213 -0.829 0 CA-C-N 121.367 1.894 . . . . 0.0 108.051 175.366 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.747 HD13 HD11 ' A' ' 30' ' ' ILE . 8.3 mt -52.76 -33.67 49.47 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-N 120.941 1.7 . . . . 0.0 113.116 -172.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.33 26.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 121.82 2.1 . . . . 0.0 115.097 169.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.96 -29.47 20.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 120.446 1.475 . . . . 0.0 111.661 160.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 3.3 mt -91.51 -15.91 28.04 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.372 1.469 . . . . 0.0 113.515 173.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.48 12.04 16.03 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.074 1.797 . . . . 0.0 116.372 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 30' ' ' ILE . 19.1 t -77.13 135.32 66.64 Favored Pre-proline 0 CA--C 1.557 1.234 0 CA-C-N 119.287 1.544 . . . . 0.0 112.025 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.3 147.7 78.7 Favored 'Trans proline' 0 C--N 1.359 1.079 0 C-N-CA 124.431 3.421 . . . . 0.0 113.632 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.65 ' HA ' HG22 ' A' ' 30' ' ' ILE . 7.0 mm-40 -68.96 -62.08 1.53 Allowed 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 119.754 1.161 . . . . 0.0 113.997 -173.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -61.85 -25.73 67.71 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 122.806 2.548 . . . . 0.0 111.431 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.4 m -74.88 -35.53 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.634 1.174 . . . . 0.0 113.502 172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.747 HD11 HD13 ' A' ' 20' ' ' LEU . 2.6 tp -89.21 -30.95 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 120.447 1.476 . . . . 0.0 112.766 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.55 -26.18 61.64 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 124.738 1.215 . . . . 0.0 109.435 176.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -81.44 -14.36 57.17 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.861 1.21 . . . . 0.0 113.903 163.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.729 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -98.16 -37.54 9.67 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 115.836 1.791 . . . . 0.0 115.836 -175.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -101.56 14.54 31.65 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 126.219 1.808 . . . . 0.0 109.669 165.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.26 143.89 53.36 Favored Pre-proline 0 N--CA 1.468 0.444 0 O-C-N 121.358 -0.839 . . . . 0.0 109.38 166.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -64.73 -179.76 1.07 Allowed 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.899 1.733 . . . . 0.0 110.394 172.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.2 -4.9 83.05 Favored Glycine 0 N--CA 1.477 1.414 0 C-N-CA 126.527 2.013 . . . . 0.0 114.13 -161.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.733 ' HB ' HD23 ' A' ' 10' ' ' LEU . 55.0 t -62.16 127.3 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 C-N-CA 126.922 2.089 . . . . 0.0 111.921 161.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.3 t -71.0 111.44 4.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 O-C-N 120.858 -1.151 . . . . 0.0 108.479 164.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.427 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -132.22 79.47 1.86 Allowed 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.095 0.558 . . . . 0.0 111.623 177.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -80.83 99.24 8.2 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 122.97 0.508 . . . . 0.0 110.325 -173.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.466 HG23 ' HB2' ' A' ' 8' ' ' TYR . 2.0 tp -91.67 97.69 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 125.587 1.555 . . . . 0.0 108.668 163.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 50' ' ' THR . 1.6 tt -102.55 101.26 11.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 125.881 1.672 . . . . 0.0 108.124 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 m -112.04 137.95 42.8 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 123.625 1.678 . . . . 0.0 111.163 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.426 HD21 HG12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -167.27 71.46 0.11 Allowed 'General case' 0 C--O 1.211 -0.971 0 N-CA-C 105.302 -2.111 . . . . 0.0 105.302 -172.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 43.64 -96.5 0.01 OUTLIER Glycine 0 N--CA 1.475 1.293 0 O-C-N 120.397 -1.439 . . . . 0.0 116.112 176.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -74.08 16.45 0.23 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 125.97 1.708 . . . . 0.0 113.594 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.83 109.36 4.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 128.406 2.682 . . . . 0.0 108.317 177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.772 ' HB2' HG22 ' A' ' 63' ' ' VAL . 18.6 m-85 -134.88 119.39 18.02 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 170.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.53 ' HB ' HG23 ' A' ' 43' ' ' ILE . 1.4 m -135.68 142.29 45.1 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 128.534 2.734 . . . . 0.0 106.992 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.575 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.9 OUTLIER -142.74 115.51 8.69 Favored 'General case' 0 C--O 1.216 -0.678 0 C-N-CA 123.097 0.559 . . . . 0.0 110.114 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 1.8 pttp -131.9 146.05 51.88 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -173.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.45 134.38 47.74 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 110.185 168.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.7 15.28 13.58 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.797 1.639 . . . . 0.0 111.897 175.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.506 ' HB3' HG13 ' A' ' 38' ' ' VAL . 2.8 p -71.12 32.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 127.251 2.22 . . . . 0.0 115.52 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.87 -41.6 2.19 Favored Glycine 0 C--O 1.228 -0.251 0 C-N-CA 126.735 2.112 . . . . 0.0 110.469 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.2 tpt -82.62 112.08 19.17 Favored 'General case' 0 C--O 1.222 -0.347 0 O-C-N 121.506 -0.996 . . . . 0.0 110.172 169.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -75.56 79.91 2.56 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.634 1.174 . . . . 0.0 112.731 175.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.7 m -128.95 133.66 47.91 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.68 0.993 . . . . 0.0 113.68 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 9.4 t -132.16 137.05 47.5 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.775 1.23 . . . . 0.0 109.99 175.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' HG21 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -121.32 109.04 14.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 127.544 2.338 . . . . 0.0 107.537 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 pt -80.17 -167.18 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 C-N-CA 124.331 1.052 . . . . 0.0 111.734 173.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.772 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.5 t -67.38 131.14 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 126.065 1.746 . . . . 0.0 110.034 -178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 83' ' ' LYS . 75.6 m-20 47.3 58.95 4.39 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 172.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 -140.56 -172.62 3.48 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.958 1.303 . . . . 0.0 112.087 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -129.54 161.25 30.92 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.071 -1.643 . . . . 0.0 111.061 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG23 ' HB2' ' A' ' 80' ' ' SER . 1.3 m -163.12 154.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.939 0.876 . . . . 0.0 112.753 -165.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -134.49 128.87 34.27 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.153 1.381 . . . . 0.0 108.616 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -133.07 144.7 50.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 O-C-N 121.505 -0.747 . . . . 0.0 110.212 174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -99.52 161.63 3.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 114.742 -1.117 . . . . 0.0 109.386 157.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.66 153.05 34.96 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.474 1.51 . . . . 0.0 111.662 171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.86 -53.93 3.04 Favored Glycine 0 N--CA 1.473 1.135 0 O-C-N 121.504 -0.748 . . . . 0.0 114.838 -169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -82.75 -8.66 59.57 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.261 1.208 . . . . 0.0 114.261 -175.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.729 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.6 p -117.44 -25.56 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.226 1.811 . . . . 0.0 113.203 178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 69.67 12.83 8.15 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-O 117.708 -1.139 . . . . 0.0 112.706 -177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 1.3 mmt -66.91 108.48 2.59 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 120.483 1.492 . . . . 0.0 111.197 178.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -98.66 84.01 3.07 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 127.814 2.445 . . . . 0.0 109.648 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -112.87 160.08 12.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 122.162 0.982 . . . . 0.0 110.712 -175.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.2 160.52 16.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.582 1.182 . . . . 0.0 112.44 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.584 ' HB2' HG23 ' A' ' 67' ' ' VAL . 3.8 m -147.14 143.48 28.29 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.064 -1.425 . . . . 0.0 110.072 -170.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -136.32 93.48 2.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.062 0.945 . . . . 0.0 109.024 -175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 61' ' ' LEU . 1.7 p -77.01 150.95 35.8 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 125.93 1.692 . . . . 0.0 111.79 -174.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 64' ' ' ASN . 0.1 OUTLIER -163.14 111.35 1.26 Allowed 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.337 1.455 . . . . 0.0 110.729 -176.252 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -96.03 137.42 35.13 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 125.124 1.37 . . . . 0.0 110.928 -174.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -130.16 46.85 2.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 123.03 1.395 . . . . 0.0 110.426 -169.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.25 -101.08 1.44 Allowed Glycine 0 C--N 1.338 0.688 0 CA-C-N 114.708 -1.133 . . . . 0.0 110.825 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.6 p -92.13 30.14 1.5 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.625 1.17 . . . . 0.0 113.683 -175.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.25 137.52 1.51 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.889 1.675 . . . . 0.0 108.618 174.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 84' ' ' LEU . 9.4 tt -103.18 149.84 24.27 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 175.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 41.2 t -124.91 151.28 30.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 120.235 -1.541 . . . . 0.0 108.735 168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.453 ' CG1' HG22 ' A' ' 82' ' ' THR . 2.8 m -138.98 120.64 16.49 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 CA-C-N 120.295 1.407 . . . . 0.0 110.396 170.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -80.28 114.37 19.14 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 119.299 -2.126 . . . . 0.0 110.308 177.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -100.95 117.64 35.39 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.332 0.653 . . . . 0.0 111.449 -175.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -95.02 133.99 38.2 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.038 0.923 . . . . 0.0 109.625 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.414 ' HG ' ' CD2' ' A' ' 23' ' ' LEU . 2.9 mm? -109.85 105.74 57.52 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 176.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -53.43 -25.52 32.09 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.533 2.822 . . . . 0.0 115.851 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -64.65 -0.38 1.39 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.089 2.156 . . . . 0.0 114.857 174.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 109.34 -23.43 22.76 Favored Glycine 0 N--CA 1.474 1.194 0 C-N-CA 126.14 1.829 . . . . 0.0 114.535 172.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 49.16 1.11 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.466 1.506 . . . . 0.0 112.534 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.84 163.43 2.65 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.55 -1.344 . . . . 0.0 113.697 171.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.07 -158.96 9.1 Favored Glycine 0 N--CA 1.469 0.846 0 O-C-N 121.108 -0.995 . . . . 0.0 111.465 175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.1 p -129.07 118.17 22.07 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.686 1.243 . . . . 0.0 111.081 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 8.8 mtp180 -82.01 141.98 32.77 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.101 0.96 . . . . 0.0 110.433 172.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 90' ' ' VAL 0.267 10.0 t -136.96 128.55 28.64 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 119.638 -1.914 . . . . 0.0 111.685 174.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CE1' HD12 ' A' ' 114' ' ' LEU . 4.5 m-30 -116.73 94.97 4.81 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.872 1.269 . . . . 0.0 112.974 -166.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -68.93 139.2 55.09 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.529 -173.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.461 ' HA ' ' CE1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -94.69 123.64 38.26 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 124.646 1.179 . . . . 0.0 111.112 -178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.54 146.8 8.59 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.397 1.879 . . . . 0.0 110.175 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.492 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 11.7 t0 -69.61 -50.18 46.89 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 122.784 1.278 . . . . 0.0 111.763 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' HD13 ' A' ' 128' ' ' ILE . 14.1 mtpp -69.72 12.62 0.18 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 116.881 -1.533 . . . . 0.0 113.573 174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.04 148.44 4.77 Favored Glycine 0 C--O 1.218 -0.856 0 CA-C-N 121.208 1.822 . . . . 0.0 114.732 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.461 ' CE1' ' HA ' ' A' ' 107' ' ' PHE . 2.6 t80 -127.73 118.1 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.66 1.984 . . . . 0.0 108.233 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 105' ' ' TYR . 46.0 t -99.14 107.34 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 119.276 -0.969 . . . . 0.0 110.62 -171.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 127' ' ' PHE . 17.5 tp -65.27 88.59 0.08 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.214 2.605 . . . . 0.0 109.773 166.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -102.37 153.01 20.43 Favored 'General case' 0 N--CA 1.48 1.056 0 O-C-N 120.254 -1.529 . . . . 0.0 111.323 173.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.466 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.9 OUTLIER -131.62 100.21 5.05 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 130.424 3.49 . . . . 0.0 107.361 177.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 18.2 m -86.62 144.27 27.25 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.706 1.202 . . . . 0.0 111.005 175.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -138.68 154.0 48.58 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 126.099 1.76 . . . . 0.0 109.818 167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.11 -6.46 10.1 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.632 159.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -102.46 -31.01 10.66 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 127.05 2.14 . . . . 0.0 111.488 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.33 -170.82 1.34 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -169.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -157.76 146.14 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 O-C-N 119.797 -1.814 . . . . 0.0 108.712 179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.478 ' HA ' ' CB ' ' A' ' 15' ' ' ASN . . . -149.65 135.68 18.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 117.027 -1.463 . . . . 0.0 114.494 -172.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.65 139.65 33.06 Favored 'General case' 0 C--O 1.213 -0.856 0 CA-C-N 121.148 1.795 . . . . 0.0 113.132 -175.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.583 ' HB3' ' HA ' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -139.78 149.31 43.39 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.326 1.85 . . . . 0.0 106.917 178.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 40.9 p90 -134.14 132.71 40.18 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -168.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.588 ' CE1' HD13 ' A' ' 10' ' ' LEU . 3.6 m-30 -115.98 114.74 25.02 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 126.726 2.01 . . . . 0.0 107.767 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.526 ' H ' ' HG3' ' A' ' 11' ' ' GLU . 1.1 mt -122.92 153.06 27.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 124.364 1.066 . . . . 0.0 109.849 -167.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.39 135.21 2.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.955 1.302 . . . . 0.0 113.812 175.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 130.002 3.321 . . . . 0.0 114.641 -172.696 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.277 14.8 ttt . . . . . 0 N--CA 1.5 2.065 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 49.0 t -50.43 148.96 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-N 119.229 0.922 . . . . 0.0 110.415 163.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -127.95 118.1 22.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.488 1.115 . . . . 0.0 108.829 165.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.9 tt -100.1 -51.36 3.7 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 119.288 0.949 . . . . 0.0 110.117 172.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.7 -41.25 0.69 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -172.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 132.83 -169.13 22.6 Favored Glycine 0 N--CA 1.47 0.915 0 C-N-CA 124.389 0.995 . . . . 0.0 112.044 -170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.4 p -112.85 144.31 42.62 Favored 'General case' 0 CA--C 1.502 -0.866 0 C-N-CA 124.956 1.303 . . . . 0.0 110.539 177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.525 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -119.59 149.68 41.54 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.062 177.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -116.83 172.29 7.34 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.513 1.125 . . . . 0.0 108.954 168.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -51.48 141.33 16.0 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 119.854 -1.779 . . . . 0.0 109.557 167.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.412 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 24.2 mm-40 -114.45 -66.76 1.05 Allowed 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 156.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -135.62 178.33 7.12 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 123.451 1.595 . . . . 0.0 112.491 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -144.4 146.34 32.45 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.171 1.789 . . . . 0.0 107.079 176.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -137.6 160.46 39.1 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 120.833 1.651 . . . . 0.0 107.952 164.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.32 2.95 0.68 Allowed 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 158.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 19.7 p90 -41.63 -37.66 1.21 Allowed 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 125.246 1.418 . . . . 0.0 110.104 146.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' CB ' HG21 ' A' ' 30' ' ' ILE . 10.8 pt-20 -61.64 -51.58 67.89 Favored 'General case' 0 C--O 1.213 -0.826 0 CA-C-O 117.849 -1.072 . . . . 0.0 111.272 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.09 -53.31 57.55 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.299 45.5 p90 -66.92 -48.46 68.59 Favored 'General case' 0 C--O 1.221 -0.425 0 CA-C-O 116.585 -1.674 . . . . 0.0 111.578 177.291 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.6 mt -60.59 -25.39 66.19 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 121.055 1.752 . . . . 0.0 112.83 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.4 -27.47 20.41 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 126.793 2.037 . . . . 0.0 112.976 175.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.18 -18.56 64.6 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.013 0.925 . . . . 0.0 111.829 160.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 0.1 OUTLIER -98.41 -3.03 37.75 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.407 1.483 . . . . 0.0 112.702 164.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 93.76 9.24 60.05 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 117.624 1.809 . . . . 0.0 117.624 167.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.1 t -68.15 146.59 98.15 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-N 120.185 1.993 . . . . 0.0 110.358 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -71.7 140.64 36.1 Favored 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 123.941 3.094 . . . . 0.0 113.716 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -57.22 -50.76 71.87 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.514 1.526 . . . . 0.0 114.82 -170.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.07 -18.81 55.31 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 119.811 -1.806 . . . . 0.0 112.19 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -74.14 -29.29 61.74 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 118.896 0.771 . . . . 0.0 112.038 163.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG21 ' CB ' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -69.62 -44.12 79.79 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 C-N-CA 128.099 2.56 . . . . 0.0 111.245 179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtpt -72.53 -12.87 61.25 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.802 -1.187 . . . . 0.0 112.825 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 7.0 ptpp? -109.79 5.93 23.09 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 126.226 1.81 . . . . 0.0 112.99 167.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 74' ' ' VAL . . . -103.43 -28.92 11.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.997 1.719 . . . . 0.0 112.5 174.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 32.89 5.27 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.027 1.731 . . . . 0.0 109.632 169.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -54.29 153.0 10.39 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 124.929 1.292 . . . . 0.0 110.605 168.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.54 -163.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.4 2.733 . . . . 0.0 109.901 170.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 70.01 -4.56 7.77 Favored Glycine 0 N--CA 1.47 0.943 0 O-C-N 120.578 -1.326 . . . . 0.0 114.364 -175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.441 HG11 ' CE2' ' A' ' 40' ' ' TYR . 67.2 t -60.41 132.02 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 159.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 77.5 t -74.8 88.41 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 160.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 38' ' ' VAL . 54.3 m-85 -84.46 135.36 34.28 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 154.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -125.06 127.01 46.28 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.401 HG12 ' HB2' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -140.58 103.63 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 122.254 1.026 . . . . 0.0 108.38 -167.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.11 101.01 11.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -165.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.46 124.4 70.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 120.611 -1.306 . . . . 0.0 114.51 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -154.04 47.74 0.62 Allowed 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.742 2.417 . . . . 0.0 111.601 -171.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 60.45 -94.86 0.08 OUTLIER Glycine 0 N--CA 1.476 1.314 0 O-C-N 120.739 -1.226 . . . . 0.0 112.914 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -77.22 30.83 0.14 Allowed 'General case' 0 CA--C 1.554 1.1 0 O-C-N 121.376 -1.073 . . . . 0.0 112.891 171.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.35 109.05 1.28 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.989 2.116 . . . . 0.0 107.727 176.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.47 ' HB3' ' CZ ' ' A' ' 51' ' ' PHE . 32.9 m-85 -139.37 121.35 15.62 Favored 'General case' 0 CA--C 1.553 1.066 0 CA-C-O 117.906 -1.045 . . . . 0.0 109.638 176.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.3 m -139.9 128.01 22.35 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 125.696 1.598 . . . . 0.0 110.65 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.613 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -132.79 97.35 4.02 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.862 1.265 . . . . 0.0 111.445 -170.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.62 157.06 22.6 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.608 -1.308 . . . . 0.0 114.067 -170.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -119.43 138.05 53.36 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 128.632 2.773 . . . . 0.0 108.17 169.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.41 17.83 3.67 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 120.321 -1.487 . . . . 0.0 113.348 -175.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.426 ' HB3' HG13 ' A' ' 38' ' ' VAL . 3.6 p -72.82 12.23 0.54 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.242 1.941 . . . . 0.0 116.242 -174.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.34 -28.6 3.27 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 126.221 1.867 . . . . 0.0 111.679 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.64 129.85 34.71 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.471 1.508 . . . . 0.0 108.257 161.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -86.6 56.62 4.08 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.239 1.016 . . . . 0.0 111.457 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.2 m -88.93 113.33 24.35 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 125.093 1.357 . . . . 0.0 112.488 -165.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.7 t -137.1 137.32 39.15 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 120.512 1.506 . . . . 0.0 111.323 169.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.8 pp -133.38 149.4 51.84 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.205 1.802 . . . . 0.0 108.968 175.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.75 -131.44 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 125.757 1.623 . . . . 0.0 107.534 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG22 ' HB2' ' A' ' 49' ' ' PHE . 0.5 OUTLIER -92.3 149.0 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 120.917 1.69 . . . . 0.0 109.539 -177.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 51.41 56.07 8.48 Favored 'General case' 0 CA--C 1.547 0.839 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 161.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -142.73 -149.86 0.29 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.291 0.95 . . . . 0.0 113.311 -174.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -161.9 154.57 20.06 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 120.367 -1.458 . . . . 0.0 111.303 176.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.7 160.95 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.354 0.662 . . . . 0.0 112.556 -178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -120.97 138.52 54.11 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.399 1.88 . . . . 0.0 110.529 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.47 136.05 15.16 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.826 0.85 . . . . 0.0 111.737 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -83.2 160.54 3.54 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.151 0 C-N-CA 124.491 1.116 . . . . 0.0 111.492 170.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.756 HD23 ' CG1' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -125.32 155.77 39.71 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 120.771 -1.206 . . . . 0.0 112.744 170.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -62.69 -79.14 0.15 Allowed Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.966 1.746 . . . . 0.0 115.969 -162.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.9 m -62.62 -54.76 34.68 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.716 1.207 . . . . 0.0 113.04 -173.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.756 ' CG1' HD23 ' A' ' 71' ' ' LEU . 2.0 p -51.82 -28.43 9.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 129.797 3.239 . . . . 0.0 114.088 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.7 m120 60.75 26.61 16.4 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 125.291 1.436 . . . . 0.0 113.627 173.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.557 ' O ' HD22 ' A' ' 71' ' ' LEU . 12.9 ttm -112.33 150.07 31.54 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 120.823 -1.173 . . . . 0.0 113.378 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -108.26 132.34 53.78 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 130.426 3.49 . . . . 0.0 111.353 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pp -148.84 166.3 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 126.515 1.926 . . . . 0.0 110.961 -177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.77 151.32 38.99 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 114.953 1.464 . . . . 0.0 114.953 -178.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 67.5 m -134.78 122.44 22.11 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.099 1.76 . . . . 0.0 110.232 -177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -110.6 101.35 10.02 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 110.973 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.5 p -84.31 139.1 32.53 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.842 1.257 . . . . 0.0 111.193 -169.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.19 126.51 10.72 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 125.084 1.353 . . . . 0.0 109.91 -177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.54 137.73 35.52 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.782 1.233 . . . . 0.0 109.571 -179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -131.75 83.07 2.07 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 123.76 1.743 . . . . 0.0 109.595 173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.72 -104.53 1.48 Allowed Glycine 0 CA--C 1.523 0.557 0 O-C-N 120.792 -1.192 . . . . 0.0 111.756 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 77.6 p -108.7 26.17 10.86 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.71 1.604 . . . . 0.0 113.014 -172.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -164.53 157.53 17.2 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.526 1.53 . . . . 0.0 110.428 -175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.613 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 6.3 tt -112.42 155.53 24.05 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 120.085 -1.634 . . . . 0.0 111.155 -176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -114.55 147.68 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 127.272 2.229 . . . . 0.0 108.034 169.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.97 116.77 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 CA-C-N 120.122 1.328 . . . . 0.0 110.39 160.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.97 111.35 4.34 Favored 'General case' 0 CA--C 1.542 0.643 0 O-C-N 120.45 -1.406 . . . . 0.0 108.031 172.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.8 p -100.16 111.1 23.38 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.724 1.147 . . . . 0.0 110.319 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -96.13 130.01 43.28 Favored 'General case' 0 CA--C 1.518 -0.253 0 C-N-CA 123.346 0.659 . . . . 0.0 109.951 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -114.16 103.45 55.11 Favored Pre-proline 0 CA--C 1.545 0.762 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -54.99 -17.46 14.31 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 125.283 3.989 . . . . 0.0 117.949 -172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -64.81 -7.63 11.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.979 1.263 . . . . 0.0 112.732 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 116.17 -18.51 14.01 Favored Glycine 0 N--CA 1.47 0.937 0 C-N-CA 125.945 1.736 . . . . 0.0 113.725 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.74 48.43 1.28 Allowed 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.73 2.012 . . . . 0.0 112.163 -172.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.57 152.51 18.19 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 120.635 -1.291 . . . . 0.0 113.287 172.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.01 -162.92 10.41 Favored Glycine 0 N--CA 1.473 1.147 0 C-N-CA 125.168 1.365 . . . . 0.0 112.414 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 p -128.14 123.78 35.28 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.32 1.06 . . . . 0.0 110.53 173.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -89.71 154.28 20.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.73 1.212 . . . . 0.0 112.048 168.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.29 128.14 27.28 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 127.028 2.131 . . . . 0.0 108.449 178.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -117.39 80.68 1.53 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 127.466 2.306 . . . . 0.0 110.424 -170.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -64.13 140.47 58.87 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -128.11 124.31 36.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.371 1.468 . . . . 0.0 111.154 -173.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 47.5 t -163.71 148.19 10.55 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.582 1.153 . . . . 0.0 110.188 -166.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -51.27 -47.85 62.37 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.506 0.594 . . . . 0.0 111.508 179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -75.19 2.86 9.86 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 150.36 149.26 4.97 Favored Glycine 0 C--N 1.342 0.868 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 170.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -114.29 107.11 15.15 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 127.734 2.414 . . . . 0.0 109.5 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 31.4 t -113.37 120.59 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 118.718 0.69 . . . . 0.0 111.766 -160.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.496 HD21 ' CE2' ' A' ' 127' ' ' PHE . 0.0 OUTLIER -94.97 82.72 3.85 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.835 2.054 . . . . 0.0 109.114 -173.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.7 150.48 25.08 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.319 1.448 . . . . 0.0 110.183 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.72 99.61 4.37 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 121.493 1.951 . . . . 0.0 111.176 173.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.0 p -83.57 118.86 24.09 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 122.131 0.967 . . . . 0.0 111.351 178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -111.38 168.54 9.45 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.052 1.341 . . . . 0.0 109.862 167.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -65.99 -35.15 90.28 Favored Glycine 0 CA--C 1.532 1.112 0 O-C-N 121.481 -0.762 . . . . 0.0 111.293 167.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.27 -57.79 4.49 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 126.79 2.036 . . . . 0.0 111.434 179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 1.5 mpt? -143.08 -178.41 5.82 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.123 1.769 . . . . 0.0 113.189 -170.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.42 125.73 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 O-C-N 121.066 -1.021 . . . . 0.0 109.835 174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -100.52 169.19 9.24 Favored 'General case' 0 C--O 1.215 -0.754 0 C-N-CA 124.79 1.236 . . . . 0.0 113.668 177.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -177.85 120.18 0.1 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 127.128 2.171 . . . . 0.0 112.01 -175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HB2' HD23 ' A' ' 114' ' ' LEU . 27.3 mtp180 -128.79 168.66 15.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 130.012 3.325 . . . . 0.0 107.446 -177.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -158.54 132.01 7.52 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 119.258 3.058 . . . . 0.0 119.258 -178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.496 ' CE2' HD21 ' A' ' 114' ' ' LEU . 5.0 m-85 -113.26 120.4 41.06 Favored 'General case' 0 CA--C 1.559 1.305 0 C-N-CA 126.276 1.83 . . . . 0.0 109.712 -177.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 129' ' ' ARG . 5.6 mt -123.01 164.95 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 119.182 -2.199 . . . . 0.0 111.187 -176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -50.97 143.02 10.91 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -177.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.246 0.884 0 C-N-CA 129.714 3.206 . . . . 0.0 113.391 -179.094 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 69.9 t -83.19 138.57 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.767 1.627 . . . . 0.0 109.105 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -147.92 96.98 2.74 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.673 0.789 . . . . 0.0 109.688 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.07 -34.77 17.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -176.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.17 -65.68 0.43 Allowed 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 124.264 1.026 . . . . 0.0 109.921 -178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.14 -126.36 1.62 Allowed Glycine 0 C--N 1.337 0.598 0 N-CA-C 112.081 -0.408 . . . . 0.0 112.081 -169.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.2 m -160.62 140.2 10.88 Favored 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 126.656 1.982 . . . . 0.0 107.684 -170.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.487 ' CD2' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -132.23 149.1 52.46 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.474 1.11 . . . . 0.0 111.836 -178.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.14 166.03 25.91 Favored 'General case' 0 C--O 1.218 -0.595 0 O-C-N 120.532 -1.355 . . . . 0.0 113.884 166.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.684 HD12 ' HB ' ' A' ' 38' ' ' VAL . 0.2 OUTLIER -51.79 129.31 26.13 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 119.54 -1.975 . . . . 0.0 114.248 -166.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.508 ' HG3' ' HB ' ' A' ' 128' ' ' ILE . 11.1 mm-40 -114.07 -40.15 3.77 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.102 0.961 . . . . 0.0 112.515 166.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.2 mmmm -153.15 151.19 29.86 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.847 1.659 . . . . 0.0 111.111 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -134.14 129.88 36.51 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.979 1.263 . . . . 0.0 109.268 167.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.77 148.94 50.44 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.812 1.645 . . . . 0.0 108.555 176.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 123' ' ' ALA . 4.0 m120 58.83 3.45 0.31 Allowed 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 173.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.486 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 0.2 OUTLIER -49.62 -34.41 18.04 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 121.241 1.837 . . . . 0.0 107.189 154.138 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -62.75 -29.76 70.93 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.841 2.056 . . . . 0.0 114.905 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -78.49 -43.52 26.8 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 121.043 1.747 . . . . 0.0 111.211 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.326 19.7 p90 -63.6 -55.75 21.24 Favored 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 117.354 -1.739 . . . . 0.0 110.18 165.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' HB2' HD11 ' A' ' 30' ' ' ILE . 0.7 OUTLIER -55.43 -28.66 55.63 Favored 'General case' 0 CA--C 1.558 1.252 0 CA-C-N 121.959 2.163 . . . . 0.0 113.013 -176.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.96 -40.04 32.85 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 119.773 -1.829 . . . . 0.0 111.616 173.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.91 -4.09 4.14 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 19' ' ' TYR . 30.0 mt -105.93 -11.19 16.28 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.816 2.046 . . . . 0.0 112.863 167.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.75 38.58 5.48 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.413 1.006 . . . . 0.0 114.919 177.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG11 HG12 ' A' ' 74' ' ' VAL . 25.0 t -95.0 131.11 30.88 Favored Pre-proline 0 CA--C 1.564 1.493 0 C-N-CA 124.429 1.092 . . . . 0.0 110.397 167.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.435 ' O ' HG22 ' A' ' 30' ' ' ILE . 32.1 Cg_exo -63.1 136.32 55.63 Favored 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.48 4.12 . . . . 0.0 116.683 -174.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.56 ' HA ' ' CG2' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -52.26 -32.13 35.68 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 117.677 2.473 . . . . 0.0 117.677 -171.004 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -98.32 -6.53 30.72 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 120.831 1.651 . . . . 0.0 113.17 177.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.479 ' HA ' ' HE3' ' A' ' 32' ' ' LYS . 10.3 p -90.51 -48.88 6.82 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.251 1.02 . . . . 0.0 111.154 168.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.56 ' CG2' ' HA ' ' A' ' 27' ' ' GLN . 6.6 tt -59.15 -41.79 84.75 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.665 0 C-N-CA 127.337 2.255 . . . . 0.0 112.305 170.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -76.12 -29.71 57.95 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 121.701 2.046 . . . . 0.0 111.69 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 29' ' ' SER . 15.6 pttp -75.81 -26.26 57.08 Favored 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 120.605 1.548 . . . . 0.0 113.569 169.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.56 ' CB ' HG22 ' A' ' 74' ' ' VAL . . . -71.06 -61.0 1.92 Allowed 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 125.649 1.58 . . . . 0.0 112.213 172.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -79.82 -9.27 59.64 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.78 1.632 . . . . 0.0 111.987 -174.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.4 t -31.73 125.84 0.34 Allowed Pre-proline 0 C--O 1.238 0.452 0 O-C-N 124.107 0.879 . . . . 0.0 109.376 146.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -70.08 -130.21 0.01 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 122.729 2.286 . . . . 0.0 110.245 175.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.21 -24.87 1.08 Allowed Glycine 0 CA--C 1.532 1.105 0 O-C-N 118.769 -2.457 . . . . 0.0 114.547 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.684 ' HB ' HD12 ' A' ' 10' ' ' LEU . 44.3 t -46.81 137.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.835 1.654 . . . . 0.0 110.14 168.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 87.5 t -79.9 102.6 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 119.997 -1.69 . . . . 0.0 108.798 163.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.468 ' CD1' ' CE2' ' A' ' 127' ' ' PHE . 0.8 OUTLIER -107.25 80.73 1.45 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 179.155 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.47 112.09 12.62 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.045 1.338 . . . . 0.0 111.574 -169.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.566 HD11 HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -123.65 111.51 29.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 124.111 0.965 . . . . 0.0 109.701 177.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 14.1 pt -105.85 114.2 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 O-C-N 121.275 -0.891 . . . . 0.0 108.604 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.566 HG13 HD11 ' A' ' 42' ' ' ILE . 3.8 m -133.22 135.98 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 CA-C-O 123.023 1.392 . . . . 0.0 113.896 -176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -172.91 79.34 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 113.705 -1.588 . . . . 0.0 109.874 -168.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 50.61 -99.49 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 126.797 2.141 . . . . 0.0 113.508 174.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -67.43 7.69 0.43 Allowed 'General case' 0 CA--C 1.554 1.111 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.16 102.71 3.39 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.856 1.663 . . . . 0.0 110.467 -171.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.48 ' HB2' HG22 ' A' ' 63' ' ' VAL . 9.7 m-85 -129.21 124.0 33.45 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-N 119.248 0.931 . . . . 0.0 110.992 174.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 27.6 m -134.05 145.93 49.87 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 127.205 2.202 . . . . 0.0 108.25 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.745 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -151.34 129.1 11.58 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.785 1.234 . . . . 0.0 108.586 -175.008 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.9 pttt -151.2 146.69 26.27 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 119.55 1.068 . . . . 0.0 113.871 -173.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.9 p -100.73 142.32 32.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.582 1.083 . . . . 0.0 111.09 162.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.17 21.84 6.19 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 126.923 2.089 . . . . 0.0 110.992 -176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -77.83 40.81 0.33 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.997 2.119 . . . . 0.0 114.779 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.92 -45.14 1.99 Allowed Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.677 1.132 . . . . 0.0 111.444 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 54.0 mmm -67.88 126.8 30.59 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.034 0.933 . . . . 0.0 109.224 155.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -93.71 104.17 16.28 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.483 0.713 . . . . 0.0 109.483 168.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.1 m -135.77 100.49 4.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 118.754 -0.641 . . . . 0.0 110.5 -169.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 14.9 t -119.46 145.69 46.06 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 119.378 0.99 . . . . 0.0 111.273 -178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.597 HD13 HG21 ' A' ' 82' ' ' THR . 2.9 pp -142.22 172.44 12.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.437 1.895 . . . . 0.0 109.32 176.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.16 -170.02 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.785 1.234 . . . . 0.0 111.574 -176.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' A' ' 49' ' ' PHE . 3.1 t -45.79 130.64 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.47 1.508 . . . . 0.0 110.684 172.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.338 26.1 p30 45.94 31.15 1.02 Allowed 'General case' 0 CA--C 1.558 1.25 0 N-CA-C 118.529 2.788 . . . . 0.0 118.529 167.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.9 mm-40 -107.11 -157.67 0.62 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 127.99 2.516 . . . . 0.0 113.082 -178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -146.77 157.75 43.75 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 118.899 -2.376 . . . . 0.0 111.467 -176.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -150.87 159.83 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 123.14 0.576 . . . . 0.0 112.383 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -140.95 134.65 30.26 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.847 1.259 . . . . 0.0 112.153 -177.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -160.05 141.93 12.91 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 121.2 -0.938 . . . . 0.0 110.76 -175.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.8 p -103.3 121.61 54.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 124.611 1.165 . . . . 0.0 109.457 168.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -83.28 129.35 35.0 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.441 0.696 . . . . 0.0 109.415 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -87.67 -30.58 18.0 Favored Glycine 0 N--CA 1.474 1.169 0 N-CA-C 115.72 1.048 . . . . 0.0 115.72 -168.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.34 3.45 3.7 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 119.507 1.653 . . . . 0.0 114.685 175.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.661 HG12 HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -147.06 -23.55 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 129.246 3.018 . . . . 0.0 111.249 -150.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.3 19.67 5.2 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 127.11 2.164 . . . . 0.0 114.811 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . . . . . . . . . 16.9 mmm -108.3 124.79 50.87 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 121.155 -0.965 . . . . 0.0 112.69 -170.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.63 118.4 36.63 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 127.283 2.233 . . . . 0.0 109.14 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.77 177.18 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 121.876 0.846 . . . . 0.0 112.405 -172.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.1 159.09 39.9 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 114.449 1.278 . . . . 0.0 114.449 175.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 67' ' ' VAL . 5.5 t -139.22 130.36 26.62 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 125.528 1.531 . . . . 0.0 109.08 -176.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.91 93.83 4.19 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.83 0.852 . . . . 0.0 110.073 -172.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.597 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -70.25 135.16 48.73 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 124.678 1.191 . . . . 0.0 109.704 -175.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -141.74 132.18 25.23 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.023 -1.048 . . . . 0.0 108.436 172.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.69 134.21 34.27 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -127.98 77.57 1.77 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.04 1.336 . . . . 0.0 107.581 175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 67.76 -94.0 0.28 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.65 1.119 . . . . 0.0 113.583 174.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 88.7 p -111.65 32.92 5.07 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.806 1.642 . . . . 0.0 112.734 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.65 143.46 5.81 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.691 1.597 . . . . 0.0 111.262 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.745 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 2.3 tt -93.16 147.55 22.79 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 120.882 -1.136 . . . . 0.0 108.661 170.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 104' ' ' THR . 2.5 m -113.41 162.45 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 125.202 1.401 . . . . 0.0 108.629 163.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -147.41 103.07 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 124.055 0.942 . . . . 0.0 109.418 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -71.94 111.99 7.65 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 109.04 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.4 m -85.02 117.3 23.91 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.254 -0.904 . . . . 0.0 109.713 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -102.88 130.76 50.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.538 0.685 . . . . 0.0 110.039 173.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -120.5 98.45 48.35 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -173.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -49.49 -38.66 44.55 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.122 3.214 . . . . 0.0 114.757 -165.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -48.33 -26.46 2.04 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.737 2.415 . . . . 0.0 115.811 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 131.06 -1.55 5.44 Favored Glycine 0 N--CA 1.471 1.014 0 CA-C-O 118.535 -1.147 . . . . 0.0 115.761 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -111.09 68.47 0.66 Allowed 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 119.584 1.692 . . . . 0.0 113.041 -174.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.2 155.02 12.04 Favored 'General case' 0 CA--C 1.553 1.086 0 O-C-N 120.584 -1.323 . . . . 0.0 113.776 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -148.52 174.66 28.12 Favored Glycine 0 N--CA 1.475 1.254 0 O-C-N 120.94 -1.1 . . . . 0.0 114.426 174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.2 p -128.08 112.41 14.56 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.412 -1.052 . . . . 0.0 110.827 177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -90.84 150.14 21.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.148 1.779 . . . . 0.0 109.139 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 90' ' ' VAL . 0.9 OUTLIER -142.81 128.61 19.36 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.141 1.376 . . . . 0.0 109.748 -176.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 114' ' ' LEU . 3.9 m-30 -125.79 88.42 2.85 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 125.507 1.523 . . . . 0.0 110.77 -161.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -70.68 159.39 34.54 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 121.508 -0.745 . . . . 0.0 111.284 175.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.66 117.79 14.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 78.4 m -150.41 147.38 27.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.94 1.696 . . . . 0.0 108.433 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.406 ' HA ' ' CE1' ' A' ' 8' ' ' TYR . 20.8 t0 -61.04 -36.94 80.89 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.218 1.007 . . . . 0.0 112.908 -175.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.46 8.58 4.09 Favored 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.643 1.177 . . . . 0.0 114.025 171.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 144.65 127.38 1.99 Allowed Glycine 0 N--CA 1.47 0.917 0 N-CA-C 116.577 1.391 . . . . 0.0 116.577 175.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CD2' HD11 ' A' ' 114' ' ' LEU . 1.3 t80 -64.71 147.02 53.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.778 2.431 . . . . 0.0 109.746 149.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 23.9 t -143.2 121.5 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 119.928 1.24 . . . . 0.0 111.176 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.537 HD21 ' CE1' ' A' ' 127' ' ' PHE . 0.2 OUTLIER -96.94 90.62 5.27 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.796 2.038 . . . . 0.0 109.58 -174.11 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 123' ' ' ALA . 0.7 OUTLIER -87.69 154.77 20.32 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.925 0.89 . . . . 0.0 110.206 176.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 1.4 ttt -137.45 114.72 10.93 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 120.024 1.284 . . . . 0.0 110.183 166.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 25.9 p -95.32 118.13 31.53 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.649 0.737 . . . . 0.0 110.762 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.476 ' HB3' ' H ' ' A' ' 121' ' ' MET . . . -96.23 170.28 9.36 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-O 121.438 0.637 . . . . 0.0 110.376 166.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -73.95 -16.7 79.37 Favored Glycine 0 CA--C 1.536 1.357 0 O-C-N 121.603 -0.685 . . . . 0.0 111.953 159.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -104.42 -32.63 8.93 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 126.157 1.783 . . . . 0.0 113.439 -170.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.476 ' H ' ' HB3' ' A' ' 118' ' ' ALA . 28.7 mtt -154.61 -171.79 3.97 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 128.281 2.632 . . . . 0.0 110.63 -176.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 20.6 m -138.81 -176.68 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.902 1.281 . . . . 0.0 109.169 169.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 115' ' ' THR . . . -158.39 157.97 33.33 Favored 'General case' 0 C--O 1.226 -0.155 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.777 175.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.86 120.41 2.32 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.578 1.551 . . . . 0.0 113.465 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.447 ' HB2' HD23 ' A' ' 114' ' ' LEU . 13.4 mtp180 -122.67 173.14 7.91 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 128.442 2.697 . . . . 0.0 108.591 179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -160.83 132.16 5.61 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 119.388 3.107 . . . . 0.0 119.388 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.537 ' CE1' HD21 ' A' ' 114' ' ' LEU . 2.9 m-30 -109.87 121.0 44.22 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.853 1.661 . . . . 0.0 109.015 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.508 ' HB ' ' HG3' ' A' ' 11' ' ' GLU . 6.8 mt -119.92 156.94 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 121.517 1.962 . . . . 0.0 110.492 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -31.87 135.48 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 117.182 2.289 . . . . 0.0 117.182 -177.046 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.077 0 CA-C-O 116.904 -1.522 . . . . 0.0 109.779 162.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 11.6 ttt . . . . . 0 N--CA 1.499 2.014 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.08 151.87 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.185 0 CA-C-N 120.707 1.594 . . . . 0.0 111.349 175.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -130.64 119.85 23.06 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.103 1.361 . . . . 0.0 108.18 172.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -121.5 -36.58 3.04 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.342 1.057 . . . . 0.0 112.521 175.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -133.44 -73.81 0.49 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.917 -178.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 175.88 -133.6 2.41 Favored Glycine 0 N--CA 1.474 1.196 0 CA-C-O 118.35 -1.25 . . . . 0.0 112.024 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.0 p -151.99 135.07 15.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.211 1.805 . . . . 0.0 111.427 175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -125.98 139.93 53.03 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.406 1.483 . . . . 0.0 113.833 -171.623 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 10.5 mtpp -110.9 174.15 6.0 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.503 1.521 . . . . 0.0 110.195 172.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 38' ' ' VAL . 9.4 tp -84.3 111.3 19.28 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 118.746 -2.471 . . . . 0.0 111.521 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -98.82 -35.52 10.1 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.162 0.985 . . . . 0.0 113.156 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.76 151.89 40.56 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 122.768 1.27 . . . . 0.0 112.311 -169.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.421 ' HB3' ' CD2' ' A' ' 16' ' ' PHE . 12.2 m-20 -147.62 147.26 29.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.452 ' H ' ' HA ' ' A' ' 125' ' ' ARG . 0.4 OUTLIER -146.95 153.88 40.6 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.612 1.565 . . . . 0.0 108.6 173.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' HB3' ' HA ' ' A' ' 123' ' ' ALA . 2.0 t-20 57.97 2.49 0.18 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.913 2.085 . . . . 0.0 116.298 174.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 26.0 p90 -50.9 -36.91 40.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.287 -1.508 . . . . 0.0 110.476 163.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.519 ' OE2' ' HE3' ' A' ' 31' ' ' LYS . 4.4 pm0 -68.73 -23.35 64.33 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 127.327 2.251 . . . . 0.0 112.122 177.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -86.97 -39.68 15.47 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 121.171 1.805 . . . . 0.0 113.001 -177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.497 ' CE1' ' HA ' ' A' ' 16' ' ' PHE 0.269 52.1 p90 -67.74 -52.88 32.24 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 117.711 -1.595 . . . . 0.0 109.667 164.487 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD12 HD11 ' A' ' 30' ' ' ILE . 96.0 mt -59.68 -28.45 67.29 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 121.259 1.845 . . . . 0.0 113.219 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.55 -24.81 33.84 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 121.707 2.048 . . . . 0.0 114.569 168.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.73 -31.8 69.96 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 120.944 1.702 . . . . 0.0 111.666 162.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.453 HD12 HD23 ' A' ' 20' ' ' LEU . 3.2 mt -81.37 -9.13 59.8 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.274 1.429 . . . . 0.0 112.347 169.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 4.86 36.52 Favored Glycine 0 N--CA 1.468 0.787 0 C-N-CA 126.427 1.965 . . . . 0.0 117.541 169.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG11 HG23 ' A' ' 74' ' ' VAL . 21.8 t -72.74 135.56 80.85 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-N 120.071 1.935 . . . . 0.0 111.88 -175.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -56.51 133.04 55.52 Favored 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 124.656 3.571 . . . . 0.0 114.729 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.478 HE21 ' N ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -45.77 -52.39 11.2 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 177.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.7 -6.6 57.34 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 120.957 1.708 . . . . 0.0 113.973 -175.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 m -87.13 -34.42 19.1 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.006 0.922 . . . . 0.0 111.6 164.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.896 HD11 HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -78.62 -41.66 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 O-C-N 120.465 -1.397 . . . . 0.0 110.465 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HE3' ' OE2' ' A' ' 17' ' ' GLU . 11.7 mttt -59.02 -34.09 71.49 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 123.766 0.827 . . . . 0.0 111.908 174.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.54 -2.77 47.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 172.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.662 ' HB1' HG12 ' A' ' 74' ' ' VAL . . . -105.49 -43.37 4.97 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 124.498 1.119 . . . . 0.0 112.806 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' HB2' ' CD1' ' A' ' 16' ' ' PHE . 2.6 m-80 -97.92 22.57 9.1 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.915 1.286 . . . . 0.0 110.817 170.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -58.34 150.55 53.48 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 124.552 1.141 . . . . 0.0 110.041 164.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.7 -174.44 1.29 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.041 1.827 . . . . 0.0 110.569 169.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.49 -29.72 5.19 Favored Glycine 0 N--CA 1.472 1.044 0 O-C-N 120.922 -1.111 . . . . 0.0 111.577 -170.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 10' ' ' LEU . 31.5 t -39.06 125.73 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 C-N-CA 124.258 1.023 . . . . 0.0 109.617 154.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 70.1 t -72.64 112.77 9.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 163.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.85 92.08 3.34 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 173.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -82.13 112.21 18.96 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 120.803 -1.186 . . . . 0.0 108.803 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HD13 ' CD2' ' A' ' 51' ' ' PHE . 1.3 tp -110.08 127.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 165.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.04 119.37 58.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HD11 ' A' ' 42' ' ' ILE . 13.0 m -126.36 129.2 71.92 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-O 122.243 1.02 . . . . 0.0 112.487 171.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -160.73 64.04 0.3 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.398 1.879 . . . . 0.0 109.898 -174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.98 -100.25 0.11 Allowed Glycine 0 N--CA 1.472 1.078 0 C-N-CA 125.328 1.442 . . . . 0.0 112.825 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -77.78 38.87 0.27 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.267 1.027 . . . . 0.0 112.722 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -167.48 89.7 0.32 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.216 1.807 . . . . 0.0 109.162 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 63' ' ' VAL . 10.8 m-85 -122.01 123.47 41.71 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.441 0.696 . . . . 0.0 109.14 170.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.8 m -139.67 137.17 35.01 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 126.474 1.91 . . . . 0.0 108.373 178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.865 ' CZ ' HD13 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -137.35 130.54 30.84 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 124.798 1.239 . . . . 0.0 107.941 -174.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.7 ptmt -154.5 150.83 28.22 Favored 'General case' 0 CA--C 1.512 -0.484 0 O-C-N 120.993 -1.067 . . . . 0.0 112.983 -173.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.7 p -127.57 141.71 51.56 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 124.667 1.187 . . . . 0.0 109.519 176.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -130.96 17.64 5.1 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.41 1.084 . . . . 0.0 111.68 -173.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.424 ' HB3' HG13 ' A' ' 38' ' ' VAL . 22.2 p -81.05 37.92 0.45 Allowed 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.478 -1.389 . . . . 0.0 113.786 -173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.66 -40.73 2.45 Favored Glycine 0 C--O 1.227 -0.317 0 C-N-CA 125.748 1.642 . . . . 0.0 111.438 -173.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.17 130.35 35.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 119.066 1.433 . . . . 0.0 109.069 163.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -97.09 81.62 3.09 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.982 1.313 . . . . 0.0 108.929 177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.7 m -122.98 123.2 40.36 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 117.714 -1.136 . . . . 0.0 111.447 -166.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 12.3 t -146.21 107.95 4.31 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 121.12 1.782 . . . . 0.0 113.988 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 82' ' ' THR . 3.6 pp -109.05 179.22 4.23 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.574 1.549 . . . . 0.0 111.927 -178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pt -137.5 -175.15 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 125.502 1.521 . . . . 0.0 112.986 -176.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.476 HG22 ' HB2' ' A' ' 49' ' ' PHE . 9.3 t -40.51 123.5 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 126.21 1.804 . . . . 0.0 110.856 168.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . 0.3 20.5 p30 48.51 43.09 19.76 Favored 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 169.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -117.96 -162.88 0.9 Allowed 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.769 1.227 . . . . 0.0 112.025 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -131.19 162.56 29.68 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.765 1.626 . . . . 0.0 109.327 -176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.5 p -152.06 148.2 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 124.917 1.287 . . . . 0.0 111.61 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -120.09 137.92 53.85 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.029 1.332 . . . . 0.0 109.62 166.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.36 148.37 19.87 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 122.912 1.339 . . . . 0.0 112.16 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.9 m -108.8 158.9 8.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 113.722 -1.581 . . . . 0.0 109.618 170.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 mt -112.04 138.36 48.8 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.346 1.059 . . . . 0.0 111.327 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -70.11 -56.41 8.0 Favored Glycine 0 N--CA 1.472 1.034 0 O-C-N 121.39 -0.818 . . . . 0.0 114.646 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.551 ' HB ' ' HB2' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -86.82 -3.64 59.09 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -172.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.662 HG12 ' HB1' ' A' ' 33' ' ' ALA . 1.3 p -114.97 -16.93 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.9 1.68 . . . . 0.0 111.796 171.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.5 m120 56.09 21.89 5.5 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.886 1.674 . . . . 0.0 114.064 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.41 ' HB2' HG22 ' A' ' 74' ' ' VAL . 0.1 OUTLIER -88.71 128.21 35.61 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.603 1.561 . . . . 0.0 110.431 179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -106.77 106.72 17.38 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.85 2.06 . . . . 0.0 108.849 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -123.74 176.57 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.81 0.814 . . . . 0.0 110.818 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -134.45 164.46 27.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 122.432 1.111 . . . . 0.0 111.437 173.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.29 128.14 7.34 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.525 -0.734 . . . . 0.0 110.39 -163.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -126.18 96.72 4.81 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.315 1.046 . . . . 0.0 110.897 -167.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -75.08 141.73 43.78 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 122.76 1.267 . . . . 0.0 110.254 -175.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 125.8 12.63 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 125.124 1.37 . . . . 0.0 107.577 178.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.15 134.27 33.81 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 121.14 -0.975 . . . . 0.0 110.445 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -124.45 60.3 1.16 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 126.549 1.94 . . . . 0.0 107.704 -178.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 59.51 -96.43 0.08 OUTLIER Glycine 0 C--N 1.34 0.771 0 C-N-CA 126.442 1.972 . . . . 0.0 113.708 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 53.0 p -93.77 24.77 3.94 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 143.58 17.33 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.828 1.251 . . . . 0.0 112.246 164.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.865 HD13 ' CZ ' ' A' ' 51' ' ' PHE . 4.2 tt -88.22 140.14 29.79 Favored 'General case' 0 CA--C 1.539 0.558 0 O-C-N 120.255 -1.528 . . . . 0.0 109.859 169.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.5 t -107.13 157.54 7.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 126.52 1.928 . . . . 0.0 108.291 168.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -149.59 99.24 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 123.792 0.837 . . . . 0.0 109.642 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -68.66 95.39 0.65 Allowed 'General case' 0 CA--C 1.542 0.65 0 O-C-N 120.759 -1.213 . . . . 0.0 110.384 177.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 58.8 m -84.24 113.0 20.8 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -99.98 136.95 39.11 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.198 0.999 . . . . 0.0 109.487 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.444 ' H ' ' HG2' ' A' ' 100' ' ' LYS . 2.6 mm? -118.89 100.71 50.74 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -65.38 -9.54 22.64 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 123.968 3.112 . . . . 0.0 116.144 -168.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -63.07 -21.77 66.4 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.645 1.178 . . . . 0.0 113.007 167.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 133.03 -30.03 3.12 Favored Glycine 0 C--N 1.339 0.712 0 C-N-CA 125.612 1.577 . . . . 0.0 114.133 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -81.85 54.22 2.38 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.774 1.23 . . . . 0.0 112.785 -173.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 95' ' ' LEU . 76.0 mttt -63.9 137.67 58.13 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.439 1.096 . . . . 0.0 113.002 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.09 -156.72 6.89 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 125.197 1.379 . . . . 0.0 113.763 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.2 p -139.22 119.49 13.71 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.063 0.945 . . . . 0.0 110.194 178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 116' ' ' MET . 26.0 mtt180 -82.87 153.29 25.2 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 121.834 0.826 . . . . 0.0 110.274 163.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 12.9 t -139.95 129.11 23.75 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.39 1.076 . . . . 0.0 108.759 168.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' CG ' HD12 ' A' ' 114' ' ' LEU . 11.4 m-30 -114.84 98.15 6.67 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.196 0.998 . . . . 0.0 108.37 -171.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.03 163.0 28.47 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 121.447 -0.783 . . . . 0.0 111.288 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -119.41 142.69 47.98 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 173.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.77 143.05 16.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.919 2.088 . . . . 0.0 108.714 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -67.31 -25.81 66.21 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 119.668 -1.895 . . . . 0.0 112.587 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.476 ' HE3' HD13 ' A' ' 128' ' ' ILE . 0.0 OUTLIER -88.43 3.48 49.86 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 166.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.09 165.46 24.53 Favored Glycine 0 N--CA 1.47 0.923 0 CA-C-N 121.665 2.03 . . . . 0.0 118.027 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -126.97 98.7 5.43 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.432 1.493 . . . . 0.0 107.757 177.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.1 t -88.77 111.19 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 122.548 1.166 . . . . 0.0 111.58 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.537 HD12 ' CG ' ' A' ' 105' ' ' TYR . 0.3 OUTLIER -83.58 87.3 7.02 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 129.551 3.141 . . . . 0.0 109.914 179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 16.1 p -92.04 161.59 14.72 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.788 -1.195 . . . . 0.0 111.288 176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.16 113.55 8.51 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 125.583 1.553 . . . . 0.0 108.925 172.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' CYS . . . . . . . . . . . . . 31.8 p -92.78 134.17 35.32 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 120.099 1.318 . . . . 0.0 110.649 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -132.58 160.44 36.6 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 125.019 1.327 . . . . 0.0 110.314 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -59.46 -38.16 93.12 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 171.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -90.44 -30.72 17.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.504 1.122 . . . . 0.0 113.514 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -150.13 173.35 13.99 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 125.55 1.54 . . . . 0.0 113.29 -175.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.33 129.41 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 O-C-N 121.167 -0.958 . . . . 0.0 110.775 172.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.422 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . . . -102.82 165.36 11.09 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.37 97.42 0.19 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 127.997 2.519 . . . . 0.0 110.881 -166.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.452 ' HA ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -119.67 164.65 15.58 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.29 2.236 . . . . 0.0 107.548 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.67 119.77 4.14 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 120.554 3.538 . . . . 0.0 120.554 -172.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.41 ' CG ' HD21 ' A' ' 114' ' ' LEU . 8.8 m-30 -95.86 121.35 37.51 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 120.387 -1.446 . . . . 0.0 111.033 -178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.476 HD13 ' HE3' ' A' ' 110' ' ' LYS . 11.5 mt -121.94 154.61 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.141 1.377 . . . . 0.0 111.179 -173.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.476 ' HA ' ' HA ' ' A' ' 8' ' ' TYR . 30.1 ptt85 -42.47 139.88 1.38 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.99 1.716 . . . . 0.0 114.868 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 C--O 1.246 0.873 0 C-N-CA 126.801 2.04 . . . . 0.0 111.96 177.605 . . . . . . . . 0 0 . 1 stop_ save_